Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
GRCh38/hg38 2q22.3-24.1(chr2:143900149-158321624)x3	ACVR1|ACVR1C|ACVR2A|ARL5A|ARL6IP6|CACNB4|CCDC148|CCDC148-AS1|CYTIP|EPC2|ERMN|FLJ46875|FMNL2|GALNT13|GALNT13-AS1|GALNT5|GPD2|GTDC1|KCNJ3|KIF5C|LINC01412|LINC01817|LINC01818|LINC01876|LINC01911|LINC01920|LINC01931|LINC01966|LINC02612|LINC02993|LOC101928386|LOC101928553|LOC101929319|LOC107228318|LOC108348024|LOC110120671|LOC110120673|LOC110120674|LOC110120675|LOC110120706|LOC110120708|LOC110120710|LOC110120715|LOC110120731|LOC110120736|LOC110121086|LOC110121209|LOC111556122|LOC111721705|LOC112806051|LOC112806054|LOC112806055|LOC115945200|LOC120961787|LOC120977009|LOC121725105|LOC122819163|LOC122819164|LOC122819165|LOC122819166|LOC122819167|LOC122847293|LOC122847294|LOC122847295|LOC122847296|LOC122847297|LOC122847298|LOC126806362|LOC126806363|LOC126806364|LOC126806365|LOC126806366|LOC126806367|LOC126806368|LOC126806369|LOC126806370|LOC126806371|LOC126806372|LOC126806373|LOC126806374|LOC126806375|LOC126806376|LOC126806377|LOC126806378|LOC126806379|LOC126806380|LOC126806381|LOC126806382|LOC126806383|LOC126806384|LOC126806385|LOC126806386|LOC126806387|LOC126806388|LOC126806389|LOC129388929|LOC129388930|LOC129388931|LOC129388932|LOC129388933|LOC129388934|LOC129388935|LOC129388936|LOC129388937|LOC129934869|LOC129934870|LOC129934871|LOC129934872|LOC129934873|LOC129934874|LOC129934875|LOC129934876|LOC129934877|LOC129934878|LOC129934879|LOC129934880|LOC129934881|LOC129934882|LOC129934883|LOC129934884|LOC129934885|LOC129934886|LOC129934887|LOC129934888|LOC129934889|LOC129934890|LOC129934891|LOC129934892|LOC129934893|LOC129934894|LOC129934895|LOC129934896|LOC129934897|LOC129934898|LOC129934899|LOC129934900|LOC129934901|LOC129934902|LOC129934903|LOC129934904|LOC129934905|LOC129934906|LOC129934907|LOC129934908|LOC129934909|LOC129934910|LOC129934911|LOC129934912|LOC129934913|LOC129934914|LOC129934915|LOC129934916|LOC129934917|LOC129934918|LOC129934919|LOC129934920|LOC129934921|LOC129934922|LOC129934923|LOC129934924|LOC129934925|LOC129934926|LOC129934927|LOC129934928|LOC129934929|LOC129934930|LOC129934931|LOC129934932|LOC129934933|LOC129934934|LOC129934935|LOC129934936|LOC129934937|LOC129934938|LOC129934939|LOC129934940|LOC129934941|LOC129934942|LOC129934943|LOC129934944|LOC129934945|LOC129934946|LOC129934947|LOC129934948|LOC129934949|LOC129934950|LOC129934951|LOC129934952|LOC129934953|LOC129934954|LOC129934955|LOC129934956|LOC129934957|LOC129934958|LOC129934959|LOC129934960|LOC129934961|LOC129934962|LOC129934963|LOC129934964|LOC129934965|LOC129934966|LOC129934967|LOC129934968|LOC129934969|LOC129934970|LOC129934971|LOC129934972|LOC129934973|LOC129934974|LOC129934975|LOC132088758|LOC132088759|LOC132088760|LOC132088761|LYPD6|LYPD6B|MBD5|MIR4773-1|MIR4773-2|MIR9899|MMADHC|MMADHC-DT|NEB|NMI|NR4A2|ORC4|PRPF40A|RBM43|RIF1|RND3|RPRM|STAM2|TEX41|TNFAIP6|TRA-CGC3-1|TRG-GCC2-2|UPP2|ZEB2|ZEB2-AS1		See cases	VCV000146076	2	144657717 - 159178136	2	143900149 - 158321624	146076	155827			copy number gain		Pathogenic	Jul 30, 2009	no assertion criteria provided							
GRCh38/hg38 2q22.3-24.1(chr2:147251948-157856378)x1	ACVR1|ACVR1C|ACVR2A|ARL5A|ARL6IP6|CACNB4|CYTIP|EPC2|ERMN|FLJ46875|FMNL2|GALNT13|GALNT13-AS1|GALNT5|GPD2|KCNJ3|KIF5C|LINC01817|LINC01818|LINC01876|LINC01920|LINC01931|LINC02612|LOC101928553|LOC101929319|LOC108348024|LOC110120673|LOC110120674|LOC110120675|LOC110120708|LOC110120710|LOC110120736|LOC110121086|LOC111556122|LOC112806054|LOC112806055|LOC115945200|LOC120961787|LOC120977009|LOC122819165|LOC122819166|LOC122819167|LOC122847293|LOC122847294|LOC122847295|LOC122847296|LOC122847297|LOC122847298|LOC126806365|LOC126806366|LOC126806367|LOC126806368|LOC126806369|LOC126806370|LOC126806371|LOC126806372|LOC126806373|LOC126806374|LOC126806375|LOC126806376|LOC126806377|LOC126806378|LOC126806379|LOC126806380|LOC126806381|LOC126806382|LOC126806383|LOC126806384|LOC126806385|LOC126806386|LOC126806387|LOC126806388|LOC129388931|LOC129388932|LOC129388933|LOC129388934|LOC129388935|LOC129934882|LOC129934883|LOC129934884|LOC129934885|LOC129934886|LOC129934887|LOC129934888|LOC129934889|LOC129934890|LOC129934891|LOC129934892|LOC129934893|LOC129934894|LOC129934895|LOC129934896|LOC129934897|LOC129934898|LOC129934899|LOC129934900|LOC129934901|LOC129934902|LOC129934903|LOC129934904|LOC129934905|LOC129934906|LOC129934907|LOC129934908|LOC129934909|LOC129934910|LOC129934911|LOC129934912|LOC129934913|LOC129934914|LOC129934915|LOC129934916|LOC129934917|LOC129934918|LOC129934919|LOC129934920|LOC129934921|LOC129934922|LOC129934923|LOC129934924|LOC129934925|LOC129934926|LOC129934927|LOC129934928|LOC129934929|LOC129934930|LOC129934931|LOC129934932|LOC129934933|LOC129934934|LOC129934935|LOC129934936|LOC129934937|LOC129934938|LOC129934939|LOC129934940|LOC129934941|LOC129934942|LOC129934943|LOC129934944|LOC129934945|LOC129934946|LOC129934947|LOC129934948|LOC129934949|LOC129934950|LOC129934951|LOC129934952|LOC129934953|LOC129934954|LOC129934955|LOC129934956|LOC129934957|LOC129934958|LOC129934959|LOC129934960|LOC129934961|LOC129934962|LOC129934963|LOC129934964|LOC129934965|LOC129934966|LOC129934967|LOC129934968|LOC129934969|LOC129934970|LOC129934971|LOC132088759|LOC132088760|LOC132088761|LYPD6|LYPD6B|MBD5|MIR4773-1|MIR4773-2|MIR9899|MMADHC|MMADHC-DT|NEB|NMI|NR4A2|ORC4|PRPF40A|RBM43|RIF1|RND3|RPRM|STAM2|TNFAIP6|TRA-CGC3-1|TRG-GCC2-2		See cases	VCV000060216	2	148009516 - 158712890	2	147251948 - 157856378	60216	74811			copy number loss		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 2q23.1-24.3(chr2:148917286-163204623)x1	ACVR1|ACVR1C|ARL5A|ARL6IP6|BAZ2B|BAZ2B-AS1|CACNB4|CCDC148|CCDC148-AS1|CD302|CYTIP|DAPL1|DPP4|DPP4-DT|ERMN|FAP|FLJ46875|FMNL2|GALNT13|GALNT13-AS1|GALNT5|GCA|GCG|GPD2|IFIH1|ITGB6|KCNH7|KCNH7-AS1|KCNJ3|KIF5C|LINC01806|LINC01817|LINC01818|LINC01876|LINC01920|LINC01931|LINC02478|LINC02612|LOC101928553|LOC101929319|LOC101929532|LOC108175345|LOC108281133|LOC108348024|LOC110120673|LOC110120674|LOC110120675|LOC110120676|LOC110120708|LOC110120710|LOC110120736|LOC110121086|LOC110121120|LOC110121242|LOC111556122|LOC112806054|LOC112806055|LOC112806056|LOC114827830|LOC115945200|LOC117152610|LOC117152611|LOC120961787|LOC120977009|LOC120977010|LOC120977011|LOC120977012|LOC121725105|LOC122819166|LOC122819167|LOC122847293|LOC122847294|LOC122847295|LOC122847296|LOC122847297|LOC122847298|LOC122847299|LOC122847300|LOC122847301|LOC122847302|LOC122847303|LOC122847304|LOC122847305|LOC122847306|LOC122847307|LOC126806368|LOC126806369|LOC126806370|LOC126806371|LOC126806372|LOC126806373|LOC126806374|LOC126806375|LOC126806376|LOC126806377|LOC126806378|LOC126806379|LOC126806380|LOC126806381|LOC126806382|LOC126806383|LOC126806384|LOC126806385|LOC126806386|LOC126806387|LOC126806388|LOC126806389|LOC126806390|LOC126806391|LOC126806392|LOC126806393|LOC129388931|LOC129388932|LOC129388933|LOC129388934|LOC129388935|LOC129388936|LOC129388937|LOC129934897|LOC129934898|LOC129934899|LOC129934900|LOC129934901|LOC129934902|LOC129934903|LOC129934904|LOC129934905|LOC129934906|LOC129934907|LOC129934908|LOC129934909|LOC129934910|LOC129934911|LOC129934912|LOC129934913|LOC129934914|LOC129934915|LOC129934916|LOC129934917|LOC129934918|LOC129934919|LOC129934920|LOC129934921|LOC129934922|LOC129934923|LOC129934924|LOC129934925|LOC129934926|LOC129934927|LOC129934928|LOC129934929|LOC129934930|LOC129934931|LOC129934932|LOC129934933|LOC129934934|LOC129934935|LOC129934936|LOC129934937|LOC129934938|LOC129934939|LOC129934940|LOC129934941|LOC129934942|LOC129934943|LOC129934944|LOC129934945|LOC129934946|LOC129934947|LOC129934948|LOC129934949|LOC129934950|LOC129934951|LOC129934952|LOC129934953|LOC129934954|LOC129934955|LOC129934956|LOC129934957|LOC129934958|LOC129934959|LOC129934960|LOC129934961|LOC129934962|LOC129934963|LOC129934964|LOC129934965|LOC129934966|LOC129934967|LOC129934968|LOC129934969|LOC129934970|LOC129934971|LOC129934972|LOC129934973|LOC129934974|LOC129934975|LOC129934976|LOC129934977|LOC129934978|LOC129934979|LOC129934980|LOC129934981|LOC129934982|LOC129934983|LOC129934984|LOC129934985|LOC129934986|LOC129934987|LOC129934988|LOC129934989|LOC129934990|LOC129934991|LOC129934992|LOC129934993|LOC129934994|LOC129934995|LOC129934996|LOC129934997|LOC129934998|LOC129934999|LOC129935000|LOC129935001|LOC129935002|LOC129935003|LOC129935004|LOC129935005|LOC129935006|LOC129935007|LOC129935008|LOC129935009|LOC129935010|LOC129935011|LOC129935012|LOC129935013|LOC129935014|LOC129935015|LOC129935016|LOC129935017|LOC129935018|LOC129935019|LOC129935020|LOC129935021|LOC129935022|LOC129935023|LOC129935024|LOC129935025|LOC129935026|LOC129935027|LOC129935028|LOC129935029|LOC129935030|LOC129935031|LOC129935032|LOC129935033|LOC129935034|LOC129935035|LOC129935036|LOC129935037|LOC129935038|LOC132088760|LOC132088761|LOC132088762|LOC132088763|LOC132088764|LOC132088765|LOC132088766|LOC132088767|LOC132088768|LOC132088769|LOC132088770|LOC132088771|LOC132088772|LOC132088773|LOC132088774|LOC132088775|LOC132088776|LOC132088777|LOC132088778|LOC132088779|LOC132088780|LOC132088781|LOC132088782|LOC132088783|LOC132088784|LOC132088785|LOC132088786|LOC132088787|LOC132088788|LOC132088789|LOC132088790|LOC132088791|LOC132090680|LOC132090681|LOC132090682|LOC132090683|LOC132090684|LOC132090685|LY75|LY75-CD302|LYPD6|LYPD6B|MARCHF7|MIR4773-1|MIR4773-2|MIR4785|MIR6888|MIR9899|MMADHC|MMADHC-DT|NEB|NMI|NR4A2|PKP4|PKP4-AS1|PLA2R1|PRPF40A|PSMD14|PSMD14-DT|RBM43|RBMS1|RIF1|RND3|RPRM|SLC4A10|STAM2|TANC1|TANK|TANK-AS1|TBR1|TNFAIP6|TRA-CGC3-1|TRG-GCC2-2|UPP2|WDSUB1		See cases	VCV000060219	2	149674855 - 164061133	2	148917286 - 163204623	60219	74814			copy number loss		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 2q23.3-24.2(chr2:151932344-159419734)x1	ACVR1|ACVR1C|ARL6IP6|BAZ2B|CACNB4|CCDC148|CCDC148-AS1|CYTIP|DAPL1|ERMN|FLJ46875|FMNL2|GALNT13|GALNT13-AS1|GALNT5|GPD2|KCNJ3|LINC01876|LOC110120673|LOC110120674|LOC110120675|LOC110120708|LOC110120710|LOC110120736|LOC110121120|LOC110121242|LOC111556122|LOC112806055|LOC120977010|LOC120977011|LOC121725105|LOC122847296|LOC122847297|LOC122847298|LOC122847299|LOC122847300|LOC122847301|LOC126806374|LOC126806375|LOC126806376|LOC126806377|LOC126806378|LOC126806379|LOC126806380|LOC126806381|LOC126806382|LOC126806383|LOC126806384|LOC126806385|LOC126806386|LOC126806387|LOC126806388|LOC126806389|LOC126806390|LOC129388933|LOC129388934|LOC129388935|LOC129388936|LOC129388937|LOC129934921|LOC129934922|LOC129934923|LOC129934924|LOC129934925|LOC129934926|LOC129934927|LOC129934928|LOC129934929|LOC129934930|LOC129934931|LOC129934932|LOC129934933|LOC129934934|LOC129934935|LOC129934936|LOC129934937|LOC129934938|LOC129934939|LOC129934940|LOC129934941|LOC129934942|LOC129934943|LOC129934944|LOC129934945|LOC129934946|LOC129934947|LOC129934948|LOC129934949|LOC129934950|LOC129934951|LOC129934952|LOC129934953|LOC129934954|LOC129934955|LOC129934956|LOC129934957|LOC129934958|LOC129934959|LOC129934960|LOC129934961|LOC129934962|LOC129934963|LOC129934964|LOC129934965|LOC129934966|LOC129934967|LOC129934968|LOC129934969|LOC129934970|LOC129934971|LOC129934972|LOC129934973|LOC129934974|LOC129934975|LOC129934976|LOC129934977|LOC129934978|LOC129934979|LOC129934980|LOC129934981|LOC129934982|LOC129934983|LOC129934984|LOC129934985|LOC129934986|LOC132088761|LOC132088762|LOC132088763|LOC132088764|LOC132088765|LOC132088766|LOC132088767|LOC132088768|LOC132090680|LOC132090681|LOC132090682|LOC132090683|MIR6888|NR4A2|PKP4|PKP4-AS1|PRPF40A|RPRM|STAM2|TANC1|TRA-CGC3-1|TRG-GCC2-2|UPP2|WDSUB1		See cases	VCV000154597	2	152788858 - 160276245	2	151932344 - 159419734	154597	164351			copy number loss		Pathogenic	Dec 22, 2010	no assertion criteria provided							
GRCh38/hg38 2q23.3-24.1(chr2:153609714-158185125)x1	LOC129934943|LOC129934944|LOC129934945|LOC129934946|LOC129934947|LOC129934948|LOC129934949|LOC129934950|LOC129934951|LOC129934952|LOC129934953|LOC129934954|LOC129934955|LOC129934956|LOC129934957|LOC129934958|LOC129934959|LOC129934960|LOC129934961|LOC129934962|LOC129934963|LOC129934964|LOC129934965|LOC129934966|LOC129934967|LOC129934968|LOC129934969|LOC129934970|LOC129934971|LOC129934972|LOC129934973|LOC129934974|LOC132088761|NR4A2|TRA-CGC3-1|TRG-GCC2-2|UPP2|ACVR1|ACVR1C|CCDC148|CCDC148-AS1|CYTIP|ERMN|FLJ46875|GALNT13|GALNT13-AS1|GALNT5|GPD2|KCNJ3|LINC01876|LOC110120673|LOC110120674|LOC110120675|LOC110120708|LOC110120710|LOC110120736|LOC111556122|LOC121725105|LOC122847298|LOC126806381|LOC126806382|LOC126806383|LOC126806384|LOC126806385|LOC126806386|LOC126806387|LOC126806388|LOC126806389|LOC129388933|LOC129388934|LOC129388935|LOC129934938|LOC129934939|LOC129934940|LOC129934941|LOC129934942		See cases	VCV000154896	2	154466227 - 159041637	2	153609714 - 158185125	154896	164650			copy number loss		Pathogenic	Sep 21, 2012	no assertion criteria provided							
GRCh38/hg38 2q24.1-31.1(chr2:154294042-175989372)x3	LOC129935011|LOC129935012|LOC129935013|LOC129935014|LOC129935015|LOC129935016|LOC129935017|LOC129935018|LOC129935019|LOC129935020|LOC129935021|LOC129935022|LOC129935023|LOC129935024|LOC129935025|LOC129935026|LOC129935027|LOC129935028|LOC129935029|LOC129935030|LOC129935031|LOC129935032|LOC129935033|LOC129935034|LOC129935035|LOC129935036|LOC129935037|LOC129935038|LOC129935039|LOC129935040|LOC129935041|LOC129935042|LOC129935043|LOC129935044|LOC129935045|LOC129935046|LOC129935047|LOC129935048|LOC129935049|LOC129935050|LOC129935051|LOC129935052|LOC129935053|LOC129935054|LOC129935055|LOC129935056|LOC129935057|LOC129935058|LOC129935059|LOC129935060|LOC129935061|LOC129935062|LOC129935063|LOC129935064|LOC129935065|LOC129935066|LOC129935067|LOC129935068|LOC129935069|LOC129935070|LOC129935071|LOC129935072|LOC129935073|LOC129935074|LOC129935075|LOC129935076|LOC129935077|LOC129935078|LOC129935079|LOC129935080|LOC129935081|LOC129935082|LOC129935083|LOC129935084|LOC129935085|LOC129935086|LOC129935087|LOC129935088|LOC129935089|LOC129935090|LOC129935091|LOC129935092|LOC129935093|LOC129935094|LOC129935095|LOC129935096|LOC129935097|LOC129935098|LOC129935099|LOC129935100|LOC129935101|LOC129935102|LOC129935103|LOC129935104|LOC129935105|LOC129935106|LOC129935107|LOC129935108|LOC129935109|LOC129935110|LOC129935111|LOC129935112|LOC129935113|LOC129935114|LOC129935115|LOC129935116|LOC129935117|LOC129935118|LOC129935119|LOC129935120|LOC129935121|LOC129935122|LOC129935123|LOC129935124|LOC129935125|LOC129935126|LOC129935127|LOC129935128|LOC129935129|LOC129935130|LOC129935131|LOC129935132|LOC129935133|LOC129935134|LOC129935135|LOC129935136|LOC129935137|LOC129935138|LOC129935139|LOC129935140|LOC129935141|LOC129935142|LOC129935143|LOC129935144|LOC129935145|LOC129935146|LOC129935147|LOC129935148|LOC129935149|LOC129935150|LOC129935151|LOC129935152|LOC129935153|LOC129935154|LOC129935155|LOC132088761|LOC132088762|LOC132088763|LOC132088764|LOC132088765|LOC132088766|LOC132088767|LOC132088768|LOC132088769|LOC132088770|LOC132088771|LOC132088772|LOC132088773|LOC132088774|LOC132088775|LOC132088776|LOC132088777|LOC132088778|LOC132088779|LOC132088780|LOC132088781|LOC132088782|LOC132088783|LOC132088784|LOC132088785|LOC132088786|LOC132088787|LOC132088788|LOC132088789|LOC132088790|LOC132088791|LOC132088792|LOC132088793|LOC132088794|LOC132088795|LOC132088796|LOC132088797|LOC132088798|LOC132088799|LOC132088800|LOC132088801|LOC132088802|LOC132088803|LOC132090680|LOC132090681|LOC132090682|LOC132090683|LOC132090684|LOC132090685|LOC132090686|LOC132090687|LRP2|LY75|LY75-CD302|MAP3K20|MAP3K20-AS1|MARCHF7|METAP1D|METTL5|METTL8|MIR4774|MIR4785|MIR6888|MIR933|MYO3B|MYO3B-AS1|NOSTRIN|NR4A2|OLA1|PDK1|PDK1-AS1|PHOSPHO2|PHOSPHO2-KLHL23|PKP4|PKP4-AS1|PLA2R1|PPIG|PSMD14|PSMD14-DT|RAPGEF4|RAPGEF4-AS1|RBMS1|SCN1A|SCN1A-AS1|SCN2A|SCN3A|SCN7A|SCN9A|SCRN3|SLC25A12|SLC38A11|SLC4A10|SNORA70F|SNORD3K|SP3|SP5|SP9|SPC25|SSB|STK39|TANC1|TANK|TANK-AS1|TBR1|TLK1|TRA-CGC3-1|TRG-GCC2-2|TTC21B|TTC21B-AS1|UBR3|UPP2|WDSUB1|WIPF1|XIRP2|XIRP2-AS1|ABCB11|ACVR1|ACVR1C|ATF2|ATP5MC3|B3GALT1|B3GALT1-AS1|BAZ2B|BAZ2B-AS1|BBS5|CCDC148|CCDC148-AS1|CD302|CDCA7|CERS6|CERS6-AS1|CFAP210|CHN1|CHRNA1|CIR1|COBLL1|CSRNP3|CYBRD1|CYTIP|DAPL1|DCAF17|DHRS9|DLX1|DLX2|DLX2-DT|DPP4|DPP4-DT|DYNC1I2|ERICH2|ERICH2-DT|ERMN|FAP|FASTKD1|FIGN|FLJ46875|G6PC2|GAD1|GALNT13|GALNT13-AS1|GALNT3|GALNT5|GCA|GCG|GORASP2|GPD2|GPR155|GPR155-DT|GRB14|HAT1|IFIH1|ITGA6|ITGA6-AS1|ITGB6|KCNH7|KCNH7-AS1|KCNJ3|KLHL23|KLHL41|LINC01124|LINC01305|LINC01806|LINC01876|LINC01960|LINC02478|LNPK|LOC100130256|LOC100506124|LOC101929532|LOC101929633|LOC102724058|LOC108175345|LOC108281133|LOC110120601|LOC110120624|LOC110120625|LOC110120626|LOC110120673|LOC110120674|LOC110120675|LOC110120676|LOC110120677|LOC110120678|LOC110120701|LOC110120708|LOC110120710|LOC110120725|LOC110120730|LOC110120736|LOC110120790|LOC110120809|LOC110121120|LOC110121216|LOC110121242|LOC111413009|LOC111556122|LOC112806056|LOC112806057|LOC112806058|LOC112806059|LOC112806060|LOC114827830|LOC115945201|LOC117152610|LOC117152611|LOC120977010|LOC120977011|LOC120977012|LOC120977013|LOC120977014|LOC120977015|LOC121725105|LOC121725106|LOC121725107|LOC122847298|LOC122847299|LOC122847300|LOC122847301|LOC122847302|LOC122847303|LOC122847304|LOC122847305|LOC122847306|LOC122847307|LOC122847308|LOC122847309|LOC122847310|LOC122847311|LOC122847312|LOC122847313|LOC122847314|LOC122847315|LOC122847316|LOC122847317|LOC122847318|LOC122847319|LOC122847320|LOC122861240|LOC122861241|LOC122861242|LOC122861243|LOC122861244|LOC122861245|LOC122861246|LOC126806382|LOC126806383|LOC126806384|LOC126806385|LOC126806386|LOC126806387|LOC126806388|LOC126806389|LOC126806390|LOC126806391|LOC126806392|LOC126806393|LOC126806394|LOC126806395|LOC126806396|LOC126806397|LOC126806398|LOC126806399|LOC126806400|LOC126806401|LOC126806402|LOC126806403|LOC126806404|LOC126806405|LOC126806406|LOC126806407|LOC126806408|LOC126806409|LOC126806410|LOC126806411|LOC126806412|LOC129388933|LOC129388934|LOC129388935|LOC129388936|LOC129388937|LOC129388938|LOC129388939|LOC129388940|LOC129388941|LOC129388943|LOC129388944|LOC129388945|LOC129388946|LOC129388947|LOC129388948|LOC129388949|LOC129388950|LOC129388951|LOC129388952|LOC129388953|LOC129934938|LOC129934939|LOC129934940|LOC129934941|LOC129934942|LOC129934943|LOC129934944|LOC129934945|LOC129934946|LOC129934947|LOC129934948|LOC129934949|LOC129934950|LOC129934951|LOC129934952|LOC129934953|LOC129934954|LOC129934955|LOC129934956|LOC129934957|LOC129934958|LOC129934959|LOC129934960|LOC129934961|LOC129934962|LOC129934963|LOC129934964|LOC129934965|LOC129934966|LOC129934967|LOC129934968|LOC129934969|LOC129934970|LOC129934971|LOC129934972|LOC129934973|LOC129934974|LOC129934975|LOC129934976|LOC129934977|LOC129934978|LOC129934979|LOC129934980|LOC129934981|LOC129934982|LOC129934983|LOC129934984|LOC129934985|LOC129934986|LOC129934987|LOC129934988|LOC129934989|LOC129934990|LOC129934991|LOC129934992|LOC129934993|LOC129934994|LOC129934995|LOC129934996|LOC129934997|LOC129934998|LOC129934999|LOC129935000|LOC129935001|LOC129935002|LOC129935003|LOC129935004|LOC129935005|LOC129935006|LOC129935007|LOC129935008|LOC129935009|LOC129935010		See cases	VCV000154177	2	155150555 - 176854100	2	154294042 - 175989372	154177	163928			copy number gain		Pathogenic	Mar 10, 2014	no assertion criteria provided							
GRCh38/hg38 2q24.1-24.3(chr2:154366788-167048902)x3	ACVR1|ACVR1C|BAZ2B|BAZ2B-AS1|CCDC148|CCDC148-AS1|CD302|COBLL1|CSRNP3|CYTIP|DAPL1|DPP4|DPP4-DT|ERMN|FAP|FIGN|FLJ46875|GALNT13|GALNT13-AS1|GALNT3|GALNT5|GCA|GCG|GPD2|GRB14|IFIH1|ITGB6|KCNH7|KCNH7-AS1|KCNJ3|LINC01806|LINC01876|LINC02478|LOC100506124|LOC101929532|LOC101929633|LOC102724058|LOC108175345|LOC108281133|LOC110120601|LOC110120673|LOC110120674|LOC110120675|LOC110120676|LOC110120677|LOC110120708|LOC110120710|LOC110120725|LOC110120736|LOC110121120|LOC110121242|LOC111413009|LOC111556122|LOC112806056|LOC112806057|LOC114827830|LOC117152610|LOC117152611|LOC120977010|LOC120977011|LOC120977012|LOC120977013|LOC121725105|LOC121725106|LOC122847298|LOC122847299|LOC122847300|LOC122847301|LOC122847302|LOC122847303|LOC122847304|LOC122847305|LOC122847306|LOC122847307|LOC122847308|LOC126806382|LOC126806383|LOC126806384|LOC126806385|LOC126806386|LOC126806387|LOC126806388|LOC126806389|LOC126806390|LOC126806391|LOC126806392|LOC126806393|LOC126806394|LOC126806395|LOC126806396|LOC129388933|LOC129388934|LOC129388935|LOC129388936|LOC129388937|LOC129388938|LOC129934938|LOC129934939|LOC129934940|LOC129934941|LOC129934942|LOC129934943|LOC129934944|LOC129934945|LOC129934946|LOC129934947|LOC129934948|LOC129934949|LOC129934950|LOC129934951|LOC129934952|LOC129934953|LOC129934954|LOC129934955|LOC129934956|LOC129934957|LOC129934958|LOC129934959|LOC129934960|LOC129934961|LOC129934962|LOC129934963|LOC129934964|LOC129934965|LOC129934966|LOC129934967|LOC129934968|LOC129934969|LOC129934970|LOC129934971|LOC129934972|LOC129934973|LOC129934974|LOC129934975|LOC129934976|LOC129934977|LOC129934978|LOC129934979|LOC129934980|LOC129934981|LOC129934982|LOC129934983|LOC129934984|LOC129934985|LOC129934986|LOC129934987|LOC129934988|LOC129934989|LOC129934990|LOC129934991|LOC129934992|LOC129934993|LOC129934994|LOC129934995|LOC129934996|LOC129934997|LOC129934998|LOC129934999|LOC129935000|LOC129935001|LOC129935002|LOC129935003|LOC129935004|LOC129935005|LOC129935006|LOC129935007|LOC129935008|LOC129935009|LOC129935010|LOC129935011|LOC129935012|LOC129935013|LOC129935014|LOC129935015|LOC129935016|LOC129935017|LOC129935018|LOC129935019|LOC129935020|LOC129935021|LOC129935022|LOC129935023|LOC129935024|LOC129935025|LOC129935026|LOC129935027|LOC129935028|LOC129935029|LOC129935030|LOC129935031|LOC129935032|LOC129935033|LOC129935034|LOC129935035|LOC129935036|LOC129935037|LOC129935038|LOC129935039|LOC129935040|LOC129935041|LOC129935042|LOC129935043|LOC129935044|LOC129935045|LOC129935046|LOC129935047|LOC132088761|LOC132088762|LOC132088763|LOC132088764|LOC132088765|LOC132088766|LOC132088767|LOC132088768|LOC132088769|LOC132088770|LOC132088771|LOC132088772|LOC132088773|LOC132088774|LOC132088775|LOC132088776|LOC132088777|LOC132088778|LOC132088779|LOC132088780|LOC132088781|LOC132088782|LOC132088783|LOC132088784|LOC132088785|LOC132088786|LOC132088787|LOC132088788|LOC132088789|LOC132088790|LOC132088791|LOC132088792|LOC132088793|LOC132090680|LOC132090681|LOC132090682|LOC132090683|LOC132090684|LOC132090685|LY75|LY75-CD302|MARCHF7|MIR4785|MIR6888|NR4A2|PKP4|PKP4-AS1|PLA2R1|PSMD14|PSMD14-DT|RBMS1|SCN1A|SCN1A-AS1|SCN2A|SCN3A|SCN7A|SCN9A|SLC38A11|SLC4A10|SNORA70F|TANC1|TANK|TANK-AS1|WDSUB1|TBR1|TRA-CGC3-1|TRG-GCC2-2|TTC21B|TTC21B-AS1|UPP2|XIRP2		See cases	VCV000059150	2	155223300 - 167905412	2	154366788 - 167048902	59150	73745			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
Single allele	ACVR1|ACVR1C|CYTIP|ERMN|FLJ46875|GALNT5|GPD2|KCNJ3|LINC01876|LOC110120673|LOC110120674|LOC110120675|LOC110120708|LOC110120710|LOC110120736|LOC122847298|LOC126806382|LOC126806383|LOC126806384|LOC126806385|LOC126806386|LOC126806387|LOC129388933|LOC129388934|LOC129388935|LOC129934938|LOC129934939|LOC129934940|LOC129934941|LOC129934942|LOC129934943|LOC129934944|LOC129934945|LOC129934946|LOC129934947|LOC129934948|LOC129934949|LOC129934950|LOC129934951|LOC129934952|LOC129934953|LOC129934954|LOC129934955|LOC129934956|LOC129934957|LOC129934958|LOC129934959|LOC129934960|LOC129934961|LOC129934962|LOC129934963|LOC129934964|LOC129934965|LOC129934966|LOC129934967|LOC129934968|LOC129934969|LOC129934970|LOC129934971|LOC132088761|NR4A2|TRA-CGC3-1|TRG-GCC2-2		Autism spectrum disorder	VCV000236378	2	155363751 - 158667217	2	154507239 - 157810705	236378	237933			Deletion		Likely pathogenic	Oct 12, 2015	criteria provided, single submitter							
GRCh38/hg38 2q24.1(chr2:157418173-158277521)x1	ACVR1|ACVR1C|CCDC148|CCDC148-AS1|CYTIP|LOC121725105|LOC126806386|LOC126806387|LOC126806388|LOC126806389|LOC129388936|LOC129388937|LOC129934961|LOC129934962|LOC129934963|LOC129934964|LOC129934965|LOC129934966|LOC129934967|LOC129934968|LOC129934969|LOC129934970|LOC129934971|LOC129934972|LOC129934973|LOC129934974|LOC129934975|UPP2		See cases	VCV000154128	2	158274685 - 159134033	2	157418173 - 158277521	154128	163879			copy number loss		Uncertain significance	Mar 10, 2014	no assertion criteria provided							
NM_001111067.4(ACVR1):c.*1036del	ACVR1		Progressive myositis ossificans	VCV000331672	2	158593007	2	157736495	331672	284579	rs886054984	NC_000002.12:157736494:AAAAA:AAAA	Deletion	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*791A>T	ACVR1		Progressive myositis ossificans	VCV000331673	2	158593252	2	157736740	331673	282323	rs74392193	NC_000002.12:157736739:T:A	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*762A>G	ACVR1		Progressive myositis ossificans	VCV000331674	2	158593281	2	157736769	331674	282333	rs112908089	NC_000002.12:157736768:T:C	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*752A>G	ACVR1		Progressive myositis ossificans	VCV000893589	2	158593291	2	157736779	893589	881263	rs1028134399	NC_000002.12:157736778:T:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*751T>G	ACVR1		Progressive myositis ossificans	VCV000893590	2	158593292	2	157736780	893590	881264	rs1684548613	NC_000002.12:157736779:A:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*711A>G	ACVR1		Progressive myositis ossificans	VCV000331675	2	158593332	2	157736820	331675	284580	rs550878134	NC_000002.12:157736819:T:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*686T>C	ACVR1		Progressive myositis ossificans|not provided	VCV000331676	2	158593357	2	157736845	331676	284581	rs12997	NC_000002.12:157736844:A:G	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.*500G>A	ACVR1		Progressive myositis ossificans	VCV000331677	2	158593543	2	157737031	331677	283009	rs886054985	NC_000002.12:157737030:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*421G>A	ACVR1		Progressive myositis ossificans	VCV000331678	2	158593622	2	157737110	331678	284982	rs761727358	NC_000002.12:157737109:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*358G>A	ACVR1		Progressive myositis ossificans|not provided	VCV000331679	2	158593685	2	157737173	331679	284989	rs79598188	NC_000002.12:157737172:C:T	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.*314A>C	ACVR1		Progressive myositis ossificans	VCV000331680	2	158593729	2	157737217	331680	284582	rs140005003	NC_000002.12:157737216:T:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*250C>G	ACVR1		Progressive myositis ossificans	VCV000331681	2	158593793	2	157737281	331681	285001	rs886054986	NC_000002.12:157737280:G:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*210A>C	ACVR1		Progressive myositis ossificans	VCV000331682	2	158593833	2	157737321	331682	283010	rs886054987	NC_000002.12:157737320:T:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1445_*204del (p.Pro482fs)	ACVR1	P482fs	not provided	VCV002014558	2	158593839 - 158594128	2	157737327 - 157737616	2014558	2075054			Deletion	frameshift variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*183G>A	ACVR1		Progressive myositis ossificans	VCV000331683	2	158593860	2	157737348	331683	282334	rs113598201	NC_000002.12:157737347:C:T	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*182C>T	ACVR1		Progressive myositis ossificans	VCV000893875	2	158593861	2	157737349	893875	881265	rs111262123	NC_000002.12:157737348:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*152G>A	ACVR1		Progressive myositis ossificans	VCV000331684	2	158593891	2	157737379	331684	282339	rs373670847	NC_000002.12:157737378:C:T	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*138G>A	ACVR1		Progressive myositis ossificans|not provided	VCV000331685	2	158593905	2	157737393	331685	282340	rs2228948	NC_000002.12:157737392:C:T	single nucleotide variant	3 prime UTR variant	Benign	Dec 5, 2021	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.*137C>T	ACVR1		Progressive myositis ossificans	VCV000894786	2	158593906	2	157737394	894786	881266	rs540607379	NC_000002.12:157737393:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*47C>T	ACVR1		Progressive myositis ossificans	VCV000331686	2	158593996	2	157737484	331686	283012	rs55667327	NC_000002.12:157737483:G:A	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.*45G>T	ACVR1		Progressive myositis ossificans|not provided	VCV000331687	2	158593998	2	157737486	331687	282348	rs12936	NC_000002.12:157737485:C:A	single nucleotide variant	3 prime UTR variant	Benign	Dec 5, 2021	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.1521dup (p.Asp508Ter)	ACVR1	D508*	not provided	VCV000452958	2	158594051 - 158594052	2	157737539 - 157737540	452958	442977	rs1553495017	NC_000002.12:157737539:A:AA	Duplication	nonsense	Uncertain significance	Oct 23, 2020	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1513T>C (p.Leu505=)	ACVR1		Progressive myositis ossificans|not provided	VCV000331688	2	158594060	2	157737548	331688	285002	rs3738927	NC_000002.12:157737547:A:G	single nucleotide variant	synonymous variant	Benign	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.1509C>T (p.Asp503=)	ACVR1		not provided	VCV000744051	2	158594064	2	157737552	744051	746846	rs367857827	NC_000002.12:157737551:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 18, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1506C>T (p.Leu502=)	ACVR1		Progressive myositis ossificans|not provided	VCV000331689	2	158594067	2	157737555	331689	284583	rs55788041	NC_000002.12:157737554:G:A	single nucleotide variant	synonymous variant	Benign	Jan 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.1483_1484del (p.Leu495fs)	ACVR1	L495fs	not provided	VCV002702296	2	158594089 - 158594090	2	157737577 - 157737578	2702296	2856013		NC_000002.12:157737576:AAA:A	Deletion	frameshift variant	Uncertain significance	Dec 12, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1473C>T (p.Ile491=)	ACVR1		not provided	VCV002000406	2	158594100	2	157737588	2000406	2051040		NC_000002.12:157737587:G:A	single nucleotide variant	synonymous variant	Likely benign	May 29, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1468C>T (p.Arg490Cys)	ACVR1	R490C	not provided	VCV003609118	2	158594105	2	157737593	3609118	3747706		NC_000002.12:157737592:G:A	single nucleotide variant	missense variant	Likely benign	Dec 19, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1458C>G (p.Leu486=)	ACVR1		not provided	VCV002702319	2	158594115	2	157737603	2702319	2856036		NC_000002.12:157737602:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 12, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1449C>T (p.Ser483=)	ACVR1		not provided	VCV000763274	2	158594124	2	157737612	763274	762312	rs372468278	NC_000002.12:157737611:G:A	single nucleotide variant	synonymous variant	Likely benign	May 22, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1436A>G (p.Tyr479Cys)	ACVR1	Y479C	not provided	VCV003615982	2	158594137	2	157737625	3615982	3745660		NC_000002.12:157737624:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1419A>T (p.Leu473=)	ACVR1		not provided	VCV001948837	2	158594154	2	157737642	1948837	1996513		NC_000002.12:157737641:T:A	single nucleotide variant	synonymous variant	Likely benign	Aug 8, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1406C>G (p.Ser469Cys)	ACVR1	S469C	not provided	VCV001925738	2	158594167	2	157737655	1925738	1983339		NC_000002.12:157737654:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1405T>G (p.Ser469Ala)	ACVR1	S469A	not provided	VCV002956002	2	158594168	2	157737656	2956002	3118510		NC_000002.12:157737655:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1404C>T (p.Thr468=)	ACVR1		not provided	VCV001931605	2	158594169	2	157737657	1931605	1981869		NC_000002.12:157737656:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 25, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1403C>T (p.Thr468Ile)	ACVR1	T468I	not provided	VCV002879333	2	158594170	2	157737658	2879333	3042235		NC_000002.12:157737657:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1398A>T (p.Thr466=)	ACVR1		not provided|not specified	VCV001549835	2	158594175	2	157737663	1549835	1538789	rs914942419	NC_000002.12:157737662:T:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jul 9, 2024	criteria provided, conflicting classifications							
NM_001111067.4(ACVR1):c.1396-2dup	ACVR1		not provided|Progressive myositis ossificans	VCV002438854	2	158594178 - 158594179	2	157737666 - 157737667	2438854	2414536		NC_000002.12:157737666:T:TT	Duplication	splice acceptor variant	Uncertain significance	Mar 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.1396-20T>G	ACVR1		not provided	VCV001668940	2	158594197	2	157737685	1668940	1602826	rs777518678	NC_000002.12:157737684:A:C	single nucleotide variant	intron variant	Likely benign	Oct 23, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1396-138G>A	ACVR1		not provided	VCV001289829	2	158594315	2	157737803	1289829	1279659	rs3738926	NC_000002.12:157737802:C:T	single nucleotide variant	intron variant	Benign	May 10, 2021	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.1396-231A>G	ACVR1		not provided	VCV001281624	2	158594408	2	157737896	1281624	1270618	rs76460538	NC_000002.12:157737895:T:C	single nucleotide variant	intron variant	Benign	May 10, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1395+20del	ACVR1		not provided	VCV002121078	2	158594932	2	157738420	2121078	2184130		NC_000002.12:157738419:T:	Deletion	intron variant	Likely benign	Apr 4, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1395+15T>C	ACVR1		not provided	VCV001631556	2	158594937	2	157738425	1631556	1597360	rs370008141	NC_000002.12:157738424:A:G	single nucleotide variant	intron variant	Likely benign	Jan 25, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1395+7A>G	ACVR1		not provided	VCV001583312	2	158594945	2	157738433	1583312	1601010	rs778133291	NC_000002.12:157738432:T:C	single nucleotide variant	intron variant	Benign	Nov 17, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1395+5G>A	ACVR1		Progressive myositis ossificans|not provided	VCV000748980	2	158594947	2	157738435	748980	759036	rs762094464	NC_000002.12:157738434:C:T	single nucleotide variant	intron variant	Likely benign	Oct 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.1395G>A (p.Pro465=)	ACVR1		not provided	VCV003006873	2	158594952	2	157738440	3006873	3161994		NC_000002.12:157738439:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Oct 9, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1394C>T (p.Pro465Leu)	ACVR1	P465L	Inborn genetic diseases|not provided	VCV002146537	2	158594953	2	157738441	2146537	1873642		NC_000002.12:157738440:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 11, 2023	criteria provided, conflicting classifications							
NM_001111067.4(ACVR1):c.1392C>G (p.Asp464Glu)	ACVR1	D464E	not provided	VCV000284754	2	158594955	2	157738443	284754	268991	rs886042941	NC_000002.12:157738442:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2015	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1385T>C (p.Phe462Ser)	ACVR1	F462S	not provided	VCV002900795	2	158594962	2	157738450	2900795	3057686		NC_000002.12:157738449:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1374C>G (p.Pro458=)	ACVR1		not provided	VCV002017858	2	158594973	2	157738461	2017858	2075776		NC_000002.12:157738460:G:C	single nucleotide variant	synonymous variant	Likely benign	Jul 17, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1368C>T (p.Asn456=)	ACVR1		not provided	VCV002803832	2	158594979	2	157738467	2803832	2963656		NC_000002.12:157738466:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 30, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1360A>C (p.Arg454=)	ACVR1		not provided	VCV002991877	2	158594987	2	157738475	2991877	3144487		NC_000002.12:157738474:T:G	single nucleotide variant	synonymous variant	Likely benign	Feb 22, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1350G>A (p.Val450=)	ACVR1		not provided	VCV002179590	2	158594997	2	157738485	2179590	1916111		NC_000002.12:157738484:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 25, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1348G>A (p.Val450Met)	ACVR1	V450M	not provided	VCV001379334	2	158594999	2	157738487	1379334	1486563	rs2105216859	NC_000002.12:157738486:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1338G>A (p.Lys446=)	ACVR1		not provided	VCV002889279	2	158595009	2	157738497	2889279	3044682		NC_000002.12:157738496:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1338G>C (p.Lys446Asn)	ACVR1	K446N	not provided	VCV001934872	2	158595009	2	157738497	1934872	1982548		NC_000002.12:157738496:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1331T>G (p.Met444Arg)	ACVR1	M444R	Inborn genetic diseases	VCV003264933	2	158595016	2	157738504	3264933	3425071		NC_000002.12:157738503:A:C	single nucleotide variant	missense variant	Uncertain significance	May 30, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1318A>G (p.Ser440Gly)	ACVR1	S440G	not provided	VCV001494946	2	158595029	2	157738517	1494946	1368732	rs745343863	NC_000002.12:157738516:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1310A>G (p.Asn437Ser)	ACVR1	N437S	not provided	VCV002176938	2	158595037	2	157738525	2176938	1898020		NC_000002.12:157738524:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1308C>T (p.Pro436=)	ACVR1		not provided	VCV001617572	2	158595039	2	157738527	1617572	1614425	rs2105216957	NC_000002.12:157738526:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 16, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1304T>C (p.Val435Ala)	ACVR1	V435A	not provided	VCV002778531	2	158595043	2	157738531	2778531	2943569		NC_000002.12:157738530:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1298A>G (p.Asp433Gly)	ACVR1	D433G	not provided	VCV003614959	2	158595049	2	157738537	3614959	3742478		NC_000002.12:157738536:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1297G>A (p.Asp433Asn)	ACVR1	D433N	not provided	VCV001942075	2	158595050	2	157738538	1942075	1994911		NC_000002.12:157738537:C:T	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1296C>T (p.Tyr432=)	ACVR1		not provided	VCV001618120	2	158595051	2	157738539	1618120	1527442	rs201131823	NC_000002.12:157738538:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 5, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1290G>A (p.Pro430=)	ACVR1		not provided	VCV002421529	2	158595057	2	157738545	2421529	1948950		NC_000002.12:157738544:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 7, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1272GGA[1] (p.Glu425del)	ACVR1	E425del	not provided	VCV002708377	2	158595070 - 158595072	2	157738558 - 157738560	2708377	2874542		NC_000002.12:157738557:TCCTCC:TCC	Microsatellite	inframe_deletion	Uncertain significance	Jan 9, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1265-7T>G	ACVR1		not provided	VCV002008418	2	158595089	2	157738577	2008418	2066368		NC_000002.12:157738576:A:C	single nucleotide variant	intron variant	Likely benign	Jun 19, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1264+19A>C	ACVR1		not provided	VCV001634772	2	158617373	2	157760861	1634772	1546724	rs745488328	NC_000002.12:157760860:T:G	single nucleotide variant	intron variant	Likely benign	Nov 20, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1264+13T>C	ACVR1		not provided	VCV002968754	2	158617379	2	157760867	2968754	3139063		NC_000002.12:157760866:A:G	single nucleotide variant	intron variant	Likely benign	Nov 25, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1255G>C (p.Val419Leu)	ACVR1	V419L	not provided|Inborn genetic diseases	VCV002511334	2	158617401	2	157760889	2511334	2673682		NC_000002.12:157760888:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.1253T>C (p.Met418Thr)	ACVR1	M418T	not provided	VCV001474064	2	158617403	2	157760891	1474064	1388059	rs549634108	NC_000002.12:157760890:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2025	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1250G>A (p.Arg417Gln)	ACVR1	R417Q	Inborn genetic diseases	VCV003142963	2	158617406	2	157760894	3142963	3296955		NC_000002.12:157760893:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1249C>T (p.Arg417Trp)	ACVR1	R417W	not provided	VCV002778093	2	158617407	2	157760895	2778093	2946587		NC_000002.12:157760894:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1242G>A (p.Val414=)	ACVR1		not provided	VCV000808831	2	158617414	2	157760902	808831	794805	rs897756393	NC_000002.12:157760901:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Jul 1, 2017	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1227T>C (p.Leu409=)	ACVR1		not provided	VCV002024061	2	158617429	2	157760917	2024061	2080687		NC_000002.12:157760916:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 21, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1216G>A (p.Ala406Thr)	ACVR1	A406T	not provided	VCV003624408	2	158617440	2	157760928	3624408	3761010		NC_000002.12:157760927:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1204G>T (p.Val402Phe)	ACVR1	V402F	not provided	VCV002977471	2	158617452	2	157760940	2977471	3137360		NC_000002.12:157760939:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1204G>A (p.Val402Ile)	ACVR1	V402I	not provided	VCV002421839	2	158617452	2	157760940	2421839	1945201		NC_000002.12:157760939:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1203G>T (p.Arg401Ser)	ACVR1	R401S	Inborn genetic diseases	VCV002483977	2	158617453	2	157760941	2483977	2459174		NC_000002.12:157760940:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1198A>G (p.Lys400Glu)	ACVR1	K400E	not provided	VCV000423871	2	158617458	2	157760946	423871	405336	rs1064796674	NC_000002.12:157760945:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2017	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1197T>C (p.Tyr399=)	ACVR1		not provided	VCV002869987	2	158617459	2	157760947	2869987	3020996		NC_000002.12:157760946:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 4, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1179G>T (p.Val393=)	ACVR1		not provided	VCV002958590	2	158617477	2	157760965	2958590	3125898		NC_000002.12:157760964:C:A	single nucleotide variant	synonymous variant	Likely benign	May 9, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1178T>G (p.Val393Gly)	ACVR1	V393G	not provided	VCV000808832	2	158617478	2	157760966	808832	794806	rs1574031130	NC_000002.12:157760965:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2017	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1177G>A (p.Val393Met)	ACVR1	V393M	not provided	VCV002701623	2	158617479	2	157760967	2701623	2859206		NC_000002.12:157760966:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1152C>T (p.Pro384=)	ACVR1		not provided	VCV000758141	2	158617504	2	157760992	758141	762313	rs757125368	NC_000002.12:157760991:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 2, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1149C>T (p.Ala383=)	ACVR1		not provided	VCV000754822	2	158617507	2	157760995	754822	762314	rs1574031190	NC_000002.12:157760994:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 4, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1142A>G (p.Tyr381Cys)	ACVR1	Y381C	not provided	VCV002038491	2	158617514	2	157761002	2038491	2101559		NC_000002.12:157761001:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1140C>T (p.Arg380=)	ACVR1		ACVR1-related disorder	VCV003043296	2	158617516	2	157761004	3043296	3214658		NC_000002.12:157761003:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 19, 2019	no assertion criteria provided							
NM_001111067.4(ACVR1):c.1131C>T (p.Gly377=)	ACVR1		not provided|Progressive myositis ossificans	VCV000331690	2	158617525	2	157761013	331690	285006	rs56189710	NC_000002.12:157761012:G:A	single nucleotide variant	synonymous variant	Benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.1126G>A (p.Val376Met)	ACVR1	V376M	not provided	VCV001510827	2	158617530	2	157761018	1510827	1465504	rs2105252565	NC_000002.12:157761017:C:T	single nucleotide variant	missense variant	Likely benign	Jul 5, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1124G>A (p.Arg375His)	ACVR1	R375H	not provided	VCV002875502	2	158617532	2	157761020	2875502	3041017		NC_000002.12:157761019:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1124G>C (p.Arg375Pro)	ACVR1	R375P	Progressive myositis ossificans	VCV000029596	2	158617532	2	157761020	29596	38550	rs387906590	NC_000002.12:157761019:C:G	single nucleotide variant	missense variant	Pathogenic	Mar 1, 2009	no assertion criteria provided							
NM_001111067.4(ACVR1):c.1109T>C (p.Val370Ala)	ACVR1	V370A	not provided	VCV000727207	2	158617547	2	157761035	727207	732848	rs1574031264	NC_000002.12:157761034:A:G	single nucleotide variant	missense variant	Likely benign	Feb 26, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1086C>A (p.Ser362=)	ACVR1		Progressive myositis ossificans|not provided	VCV000331691	2	158617570	2	157761058	331691	285025	rs149498219	NC_000002.12:157761057:G:T	single nucleotide variant	synonymous variant	Benign	Jan 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.1080G>A (p.Met360Ile)	ACVR1	M360I	not provided	VCV002062108	2	158617576	2	157761064	2062108	2117381		NC_000002.12:157761063:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1073C>A (p.Ala358Glu)	ACVR1	A358E	Progressive myositis ossificans	VCV000973273	2	158617583	2	157761071	973273	961502	rs1685632115	NC_000002.12:157761070:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2020	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1071G>A (p.Leu357=)	ACVR1		not provided	VCV002841307	2	158617585	2	157761073	2841307	2993460		NC_000002.12:157761072:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 27, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1067G>A (p.Gly356Asp)	ACVR1	G356D	not provided|Progressive myositis ossificans	VCV000018310	2	158617589	2	157761077	18310	33349	rs121912679	NC_000002.12:157761076:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.1067-4dup	ACVR1		ACVR1-related disorder	VCV003049883	2	158617592 - 158617593	2	157761080 - 157761081	3049883	3204959		NC_000002.12:157761080:AAA:AAAA	Duplication	intron variant	Likely benign	Mar 16, 2022	no assertion criteria provided							
NM_001111067.4(ACVR1):c.1067-8C>T	ACVR1		not provided	VCV003604651	2	158617597	2	157761085	3604651	3739520		NC_000002.12:157761084:G:A	single nucleotide variant	intron variant	Likely benign	Sep 19, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1067-13T>G	ACVR1		not provided	VCV001931981	2	158617602	2	157761090	1931981	1992156		NC_000002.12:157761089:A:C	single nucleotide variant	intron variant	Likely benign	Feb 26, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1067-15T>C	ACVR1		not provided	VCV002794998	2	158617604	2	157761092	2794998	2950948		NC_000002.12:157761091:A:G	single nucleotide variant	intron variant	Likely benign	Oct 4, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1067-16A>T	ACVR1		not provided	VCV002993448	2	158617605	2	157761093	2993448	3144766		NC_000002.12:157761092:T:A	single nucleotide variant	intron variant	Likely benign	Mar 14, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1067-225T>C	ACVR1		not provided	VCV001260871	2	158617814	2	157761302	1260871	1253359	rs16842015	NC_000002.12:157761301:A:G	single nucleotide variant	intron variant	Benign	Jun 18, 2021	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.1066+17A>G	ACVR1		not provided	VCV001611534	2	158622416	2	157765904	1611534	1552050	rs1685844568	NC_000002.12:157765903:T:C	single nucleotide variant	intron variant	Likely benign	Oct 18, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1054A>G (p.Ile352Val)	ACVR1	I352V	Inborn genetic diseases|not provided	VCV002619024	2	158622445	2	157765933	2619024	2782769		NC_000002.12:157765932:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.1038G>T (p.Lys346Asn)	ACVR1	K346N	not provided	VCV001448292	2	158622461	2	157765949	1448292	1400303	rs144048685	NC_000002.12:157765948:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1029G>A (p.Leu343=)	ACVR1		Progressive myositis ossificans	VCV000892813	2	158622470	2	157765958	892813	881267	rs1219533593	NC_000002.12:157765957:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Apr 28, 2017	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1018A>G (p.Lys340Glu)	ACVR1	K340E	not provided	VCV002003393	2	158622481	2	157765969	2003393	2055312		NC_000002.12:157765968:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1014G>T (p.Lys338Asn)	ACVR1	K338N	not provided	VCV002824847	2	158622485	2	157765973	2824847	2989349		NC_000002.12:157765972:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.988C>G (p.Pro330Ala)	ACVR1	P330A	not provided|Inborn genetic diseases	VCV002217915	2	158622511	2	157765999	2217915	2206536		NC_000002.12:157765998:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.988C>T (p.Pro330Ser)	ACVR1	P330S	not provided	VCV001502073	2	158622511	2	157765999	1502073	1411291	rs1471307549	NC_000002.12:157765998:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 9, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.983G>T (p.Gly328Val)	ACVR1	G328V	Diffuse midline glioma, H3 K27M-mutant	VCV000376363	2	158622516	2	157766004	376363	363242	rs387906589	NC_000002.12:157766003:C:A	single nucleotide variant	missense variant				Tier II - Potential	Oct 16, 2018	criteria provided, single submitter				
NM_001111067.4(ACVR1):c.983G>A (p.Gly328Glu)	ACVR1	G328E	Inborn genetic diseases|Progressive myositis ossificans|not provided	VCV000029595	2	158622516	2	157766004	29595	38549	rs387906589	NC_000002.12:157766003:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.982G>T (p.Gly328Trp)	ACVR1	G328W	Progressive myositis ossificans	VCV000029594	2	158622517	2	157766005	29594	38548	rs387906588	NC_000002.12:157766004:C:A	single nucleotide variant	missense variant	Pathogenic	Mar 1, 2009	no assertion criteria provided							
NM_001111067.4(ACVR1):c.982G>A (p.Gly328Arg)	ACVR1	G328R	Progressive myositis ossificans	VCV000029593	2	158622517	2	157766005	29593	38547	rs387906588	NC_000002.12:157766004:C:T	single nucleotide variant	missense variant	Pathogenic	Mar 1, 2009	no assertion criteria provided							
NM_001111067.4(ACVR1):c.966G>A (p.Glu322=)	ACVR1		not provided	VCV003005679	2	158622533	2	157766021	3005679	3158270		NC_000002.12:157766020:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 21, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.957G>C (p.Leu319Phe)	ACVR1	L319F	not provided	VCV002571089	2	158622542	2	157766030	2571089	2736045		NC_000002.12:157766029:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.957G>A (p.Leu319=)	ACVR1		not provided	VCV002032135	2	158622542	2	157766030	2032135	2086195		NC_000002.12:157766029:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 26, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.930G>A (p.Leu310=)	ACVR1		not provided	VCV002989706	2	158622569	2	157766057	2989706	3147435		NC_000002.12:157766056:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.920G>A (p.Arg307Gln)	ACVR1	R307Q	Inborn genetic diseases|not provided	VCV001384490	2	158622579	2	157766067	1384490	1348767	rs766547414	NC_000002.12:157766066:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.911G>A (p.Ser304Asn)	ACVR1	S304N	not provided	VCV002995345	2	158622588	2	157766076	2995345	3145367		NC_000002.12:157766075:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.896C>G (p.Thr299Ser)	ACVR1	T299S	not provided	VCV003620564	2	158622603	2	157766091	3620564	3750948		NC_000002.12:157766090:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.894T>C (p.Thr298=)	ACVR1		not provided	VCV001968737	2	158622605	2	157766093	1968737	2028745		NC_000002.12:157766092:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 4, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.893C>G (p.Thr298Ser)	ACVR1	T298S	not provided	VCV003623494	2	158622606	2	157766094	3623494	3754749		NC_000002.12:157766093:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.891T>A (p.Leu297=)	ACVR1		not provided	VCV002711913	2	158622608	2	157766096	2711913	2871641		NC_000002.12:157766095:A:T	single nucleotide variant	synonymous variant	Likely benign	Jun 20, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.879C>T (p.Asp293=)	ACVR1		not provided	VCV001533308	2	158622620	2	157766108	1533308	1530448	rs371235456	NC_000002.12:157766107:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 30, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.876C>T (p.Tyr292=)	ACVR1		Inborn genetic diseases|not provided	VCV000762450	2	158622623	2	157766111	762450	762315	rs529741006	NC_000002.12:157766110:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.870G>A (p.Ser290=)	ACVR1		not provided	VCV000713453	2	158622629	2	157766117	713453	719329	rs548498262	NC_000002.12:157766116:C:T	single nucleotide variant	synonymous variant	Benign	Jan 6, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.864G>A (p.Met288Ile)	ACVR1	M288I	not provided	VCV001902376	2	158622635	2	157766123	1902376	1954414		NC_000002.12:157766122:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.820C>T (p.His274Tyr)	ACVR1	H274Y	Progressive myositis ossificans	VCV000331692	2	158622679	2	157766167	331692	283013	rs375487177	NC_000002.12:157766166:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.819A>G (p.Arg273=)	ACVR1		not provided	VCV003011906	2	158622680	2	157766168	3011906	3177338		NC_000002.12:157766167:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 14, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.797T>A (p.Ile266Asn)	ACVR1	I266N	not provided	VCV002706550	2	158622702	2	157766190	2706550	2874004		NC_000002.12:157766189:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.791-12del	ACVR1		not provided	VCV003611172	2	158622720	2	157766208	3611172	3744738		NC_000002.12:157766207:AA:A	Deletion	intron variant	Likely benign	Nov 5, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.791-15dup	ACVR1		not provided	VCV002993230	2	158622722 - 158622723	2	157766210 - 157766211	2993230	3148369		NC_000002.12:157766210:AAAAAAA:AAAAAAAA	Duplication	intron variant	Benign	Dec 1, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.790+19C>T	ACVR1		not provided	VCV002122828	2	158626861	2	157770349	2122828	2184588		NC_000002.12:157770348:G:A	single nucleotide variant	intron variant	Likely benign	Apr 8, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.790+9A>G	ACVR1		not provided	VCV001997533	2	158626871	2	157770359	1997533	2060615		NC_000002.12:157770358:T:C	single nucleotide variant	intron variant	Likely benign	May 21, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.788T>G (p.Leu263Ter)	ACVR1	L263*	not provided	VCV002077945	2	158626882	2	157770370	2077945	2142329		NC_000002.12:157770369:A:C	single nucleotide variant	nonsense	Uncertain significance	Nov 27, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.774G>A (p.Arg258=)	ACVR1		not provided	VCV002104394	2	158626896	2	157770384	2104394	2162157		NC_000002.12:157770383:C:T	single nucleotide variant	synonymous variant	Likely benign	May 12, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.774G>C (p.Arg258Ser)	ACVR1	R258S	Progressive myositis ossificans	VCV000018311	2	158626896	2	157770384	18311	33350	rs121912680	NC_000002.12:157770383:C:G	single nucleotide variant	missense variant	Pathogenic	Mar 1, 2009	no assertion criteria provided							
NM_001111067.4(ACVR1):c.772A>G (p.Arg258Gly)	ACVR1	R258G	Progressive myositis ossificans	VCV000216885	2	158626898	2	157770386	216885	213526	rs863224846	NC_000002.12:157770385:T:C	single nucleotide variant	missense variant	Likely pathogenic	Nov 27, 2012	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.771G>A (p.Leu257=)	ACVR1		not provided	VCV002964888	2	158626899	2	157770387	2964888	3120907		NC_000002.12:157770386:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 18, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.756C>T (p.Tyr252=)	ACVR1		not provided	VCV003016343	2	158626914	2	157770402	3016343	3181826		NC_000002.12:157770401:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.747G>A (p.Thr249=)	ACVR1		not provided	VCV002177067	2	158626923	2	157770411	2177067	1898148		NC_000002.12:157770410:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 10, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.746C>T (p.Thr249Met)	ACVR1	T249M	not provided	VCV000808833	2	158626924	2	157770412	808833	794807	rs760152551	NC_000002.12:157770411:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.743A>C (p.Glu248Ala)	ACVR1	E248A	not provided	VCV002497986	2	158626927	2	157770415	2497986	2473068		NC_000002.12:157770414:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.726G>T (p.Glu242Asp)	ACVR1	E242D	not provided	VCV002742331	2	158626944	2	157770432	2742331	2903101		NC_000002.12:157770431:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.720T>G (p.Arg240=)	ACVR1		not provided	VCV002105397	2	158626950	2	157770438	2105397	2169749		NC_000002.12:157770437:A:C	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.706A>C (p.Ile236Leu)	ACVR1	I236L	not provided	VCV001435444	2	158626964	2	157770452	1435444	1432729	rs747230014	NC_000002.12:157770451:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.702G>A (p.Val234=)	ACVR1		not provided	VCV002911198	2	158626968	2	157770456	2911198	3078551		NC_000002.12:157770455:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 14, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.692A>T (p.Asn231Ile)	ACVR1	N231I	not provided	VCV002022152	2	158626978	2	157770466	2022152	2080060		NC_000002.12:157770465:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.689_690delinsGA (p.Glu230Gly)	ACVR1	E230G	not provided	VCV001972170	2	158626980 - 158626981	2	157770468 - 157770469	1972170	2029599		NC_000002.12:157770467:CT:TC	Indel	missense variant	Uncertain significance	Mar 13, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.690G>A (p.Glu230=)	ACVR1		Progressive myositis ossificans|not specified|not provided	VCV000257466	2	158626980	2	157770468	257466	250303	rs1146031	NC_000002.12:157770467:C:T	single nucleotide variant	synonymous variant	Benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.689A>G (p.Glu230Gly)	ACVR1	E230G	Inborn genetic diseases	VCV003264904	2	158626981	2	157770469	3264904	3425042		NC_000002.12:157770468:T:C	single nucleotide variant	missense variant	Uncertain significance	May 24, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.687G>A (p.Gly229=)	ACVR1		not provided	VCV001589968	2	158626983	2	157770471	1589968	1576514	rs1022630209	NC_000002.12:157770470:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 11, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.671G>A (p.Arg224Lys)	ACVR1	R224K	Inborn genetic diseases	VCV002216291	2	158626999	2	157770487	2216291	2195840		NC_000002.12:157770486:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.666G>A (p.Val222=)	ACVR1		not provided	VCV002028081	2	158627004	2	157770492	2028081	2088556		NC_000002.12:157770491:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 8, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.663G>A (p.Glu221=)	ACVR1		not provided	VCV002905726	2	158627007	2	157770495	2905726	3062176		NC_000002.12:157770494:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 10, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.658G>T (p.Gly220Cys)	ACVR1	G220C	ACVR1-related disorder	VCV003345745	2	158627012	2	157770500	3345745	3506719		NC_000002.12:157770499:C:A	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	no assertion criteria provided							
NM_001111067.4(ACVR1):c.644-3T>C	ACVR1		Progressive myositis ossificans|not provided	VCV000331693	2	158627029	2	157770517	331693	282350	rs745601993	NC_000002.12:157770516:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.644-10C>T	ACVR1		not provided	VCV002967247	2	158627036	2	157770524	2967247	3124563		NC_000002.12:157770523:G:A	single nucleotide variant	intron variant	Likely benign	Dec 6, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.644-18A>G	ACVR1		not provided	VCV003623381	2	158627044	2	157770532	3623381	3754636		NC_000002.12:157770531:T:C	single nucleotide variant	intron variant	Likely benign	Feb 29, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.643+181T>A	ACVR1		not provided	VCV001293253	2	158630419	2	157773907	1293253	1283058	rs76651097	NC_000002.12:157773906:A:T	single nucleotide variant	intron variant	Benign	May 19, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.643+166T>G	ACVR1		not provided	VCV001248182	2	158630434	2	157773922	1248182	1239839	rs16842038	NC_000002.12:157773921:A:C	single nucleotide variant	intron variant	Benign	May 11, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.643+134A>G	ACVR1		not provided	VCV001177851	2	158630466	2	157773954	1177851	1167219	rs12105359	NC_000002.12:157773953:T:C	single nucleotide variant	intron variant	Benign	May 23, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.643+16C>T	ACVR1		not provided	VCV002976546	2	158630584	2	157774072	2976546	3133901		NC_000002.12:157774071:G:A	single nucleotide variant	intron variant	Likely benign	Jan 29, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.643+15dup	ACVR1		not provided	VCV001601437	2	158630584 - 158630585	2	157774072 - 157774073	1601437	1523383	rs762714753	NC_000002.12:157774072:AAAAAAAA:AAAAAAAAA	Duplication	intron variant	Benign	Oct 3, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.643+7C>T	ACVR1		not provided|Progressive myositis ossificans	VCV000331694	2	158630593	2	157774081	331694	285029	rs12105152	NC_000002.12:157774080:G:A	single nucleotide variant	intron variant	Benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.642C>T (p.Val214=)	ACVR1		not provided	VCV003021443	2	158630601	2	157774089	3021443	3172648		NC_000002.12:157774088:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Jan 19, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.638G>C (p.Cys213Ser)	ACVR1	C213S	not provided	VCV002780912	2	158630605	2	157774093	2780912	2940765		NC_000002.12:157774092:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.638G>A (p.Cys213Tyr)	ACVR1	C213Y	not provided	VCV000546870	2	158630605	2	157774093	546870	537359	rs778765499	NC_000002.12:157774092:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.636G>C (p.Glu212Asp)	ACVR1	E212D	not provided|Inborn genetic diseases	VCV001387482	2	158630607	2	157774095	1387482	1474207	rs201872272	NC_000002.12:157774094:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 11, 2025	criteria provided, conflicting classifications							
NM_001111067.4(ACVR1):c.634G>T (p.Glu212Ter)	ACVR1	E212*	not provided	VCV002738063	2	158630609	2	157774097	2738063	2895414		NC_000002.12:157774096:C:A	single nucleotide variant	nonsense	Uncertain significance	Jul 22, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.634G>C (p.Glu212Gln)	ACVR1	E212Q	not provided	VCV000871823	2	158630609	2	157774097	871823	859008	rs1686178589	NC_000002.12:157774096:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2019	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.618C>T (p.Arg206=)	ACVR1		not provided	VCV001586848	2	158630625	2	157774113	1586848	1628788	rs746675357	NC_000002.12:157774112:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 21, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.618C>G (p.Arg206=)	ACVR1		not provided	VCV000715249	2	158630625	2	157774113	715249	719330	rs746675357	NC_000002.12:157774112:G:C	single nucleotide variant	synonymous variant	Likely benign	Feb 25, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.617G>A (p.Arg206His)	ACVR1	R206H	Epicanthus|Progressive myositis ossificans|not provided|Inborn genetic diseases	VCV000018309	2	158630626	2	157774114	18309	33348	rs121912678	NC_000002.12:157774113:C:T	single nucleotide variant	missense variant	Pathogenic	Mar 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.612G>A (p.Val204=)	ACVR1		not provided	VCV002808724	2	158630631	2	157774119	2808724	2964675		NC_000002.12:157774118:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 26, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.604_605delinsGA (p.Arg202Glu)	ACVR1	R202E	not provided	VCV002017105	2	158630638 - 158630639	2	157774126 - 157774127	2017105	2068615		NC_000002.12:157774125:CT:TC	Indel	missense variant	Uncertain significance	Sep 6, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.605G>T (p.Arg202Ile)	ACVR1	R202I	Progressive myositis ossificans	VCV000029597	2	158630638	2	157774126	29597	38551	rs387906591	NC_000002.12:157774125:C:A	single nucleotide variant	missense variant	Pathogenic	Jun 1, 2011	no assertion criteria provided							
NM_001111067.4(ACVR1):c.588T>C (p.Leu196=)	ACVR1		not provided	VCV002111916	2	158630655	2	157774143	2111916	2160737		NC_000002.12:157774142:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 14, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.587T>C (p.Leu196Pro)	ACVR1	L196P	Progressive myositis ossificans	VCV000208843	2	158630656	2	157774144	208843	205405	rs797045135	NC_000002.12:157774143:A:G	single nucleotide variant	missense variant	Pathogenic	Jan 1, 2014	no assertion criteria provided							
NM_001111067.4(ACVR1):c.572G>A (p.Gly191Glu)	ACVR1	G191E	not provided	VCV002095973	2	158630671	2	157774159	2095973	2149890		NC_000002.12:157774158:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 10, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.561G>T (p.Ser187=)	ACVR1		not provided	VCV001540366	2	158630682	2	157774170	1540366	1544983	rs377367232	NC_000002.12:157774169:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 29, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.561G>A (p.Ser187=)	ACVR1		Progressive myositis ossificans|not provided	VCV000331695	2	158630682	2	157774170	331695	284590	rs377367232	NC_000002.12:157774169:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.557A>C (p.His186Pro)	ACVR1	H186P	not provided	VCV001912793	2	158630686	2	157774174	1912793	1976894		NC_000002.12:157774173:T:G	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.550T>C (p.Leu184=)	ACVR1		not provided	VCV002709721	2	158630693	2	157774181	2709721	2874619		NC_000002.12:157774180:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 16, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.544-7A>T	ACVR1		not provided	VCV001655252	2	158630706	2	157774194	1655252	1549825	rs752894979	NC_000002.12:157774193:T:A	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.544-12C>T	ACVR1		not provided	VCV001529696	2	158630711	2	157774199	1529696	1604410	rs2105271776	NC_000002.12:157774198:G:A	single nucleotide variant	intron variant	Likely benign	Jul 12, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.544-14G>A	ACVR1		not provided	VCV002821984	2	158630713	2	157774201	2821984	2981787		NC_000002.12:157774200:C:T	single nucleotide variant	intron variant	Likely benign	Dec 30, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.544-18C>G	ACVR1		not provided	VCV003603943	2	158630717	2	157774205	3603943	3746417		NC_000002.12:157774204:G:C	single nucleotide variant	intron variant	Likely benign	Apr 16, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.544-112C>T	ACVR1		not provided	VCV001241849	2	158630811	2	157774299	1241849	1232624	rs73022059	NC_000002.12:157774298:G:A	single nucleotide variant	intron variant	Benign	May 10, 2021	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.543+20G>A	ACVR1		not provided	VCV002972600	2	158634623	2	157778111	2972600	3136380		NC_000002.12:157778110:C:T	single nucleotide variant	intron variant	Likely benign	Oct 22, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.543+13C>G	ACVR1		not provided	VCV002695963	2	158634630	2	157778118	2695963	2864650		NC_000002.12:157778117:G:C	single nucleotide variant	intron variant	Likely benign	Nov 20, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.543+12C>A	ACVR1		not provided	VCV002696187	2	158634631	2	157778119	2696187	2861042		NC_000002.12:157778118:G:T	single nucleotide variant	intron variant	Likely benign	Nov 15, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.543+2dup	ACVR1		Progressive myositis ossificans	VCV000331696	2	158634640 - 158634641	2	157778128 - 157778129	331696	284594	rs886054988	NC_000002.12:157778128:A:AA	Duplication	splice donor variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.543A>C (p.Ala181=)	ACVR1		not provided	VCV001470562	2	158634643	2	157778131	1470562	1372523	rs771401156	NC_000002.12:157778130:T:G	single nucleotide variant	synonymous variant	Uncertain significance	Jul 22, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.536C>T (p.Thr179Ile)	ACVR1	T179I	Inborn genetic diseases	VCV002314256	2	158634650	2	157778138	2314256	2306190		NC_000002.12:157778137:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 28, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.532A>C (p.Ser178Arg)	ACVR1	S178R	not provided	VCV001492903	2	158634654	2	157778142	1492903	1515739	rs759844485	NC_000002.12:157778141:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.525T>C (p.Val175=)	ACVR1		not provided	VCV002651444	2	158634661	2	157778149	2651444	2819120		NC_000002.12:157778148:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 1, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.525T>A (p.Val175=)	ACVR1		Progressive myositis ossificans|not provided	VCV000893615	2	158634661	2	157778149	893615	881268	rs371512479	NC_000002.12:157778148:A:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Mar 27, 2022	criteria provided, conflicting classifications							
NM_001111067.4(ACVR1):c.521A>G (p.Asn174Ser)	ACVR1	N174S	not provided	VCV000808834	2	158634665	2	157778153	808834	794808	rs374178479	NC_000002.12:157778152:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.511A>G (p.Ile171Val)	ACVR1	I171V	not provided	VCV002708583	2	158634675	2	157778163	2708583	2870874		NC_000002.12:157778162:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.511A>C (p.Ile171Leu)	ACVR1	I171L	not provided	VCV000871824	2	158634675	2	157778163	871824	859009	rs1686363688	NC_000002.12:157778162:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2019	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.508C>T (p.Leu170Phe)	ACVR1	L170F	not provided	VCV002829557	2	158634678	2	157778166	2829557	2980386		NC_000002.12:157778165:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.501C>G (p.Ile167Met)	ACVR1	I167M	not provided	VCV002782787	2	158634685	2	157778173	2782787	2941343		NC_000002.12:157778172:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.501C>T (p.Ile167=)	ACVR1		not provided	VCV000739042	2	158634685	2	157778173	739042	746847	rs368751955	NC_000002.12:157778172:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 24, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.485T>C (p.Val162Ala)	ACVR1	V162A	not provided	VCV001419617	2	158634701	2	157778189	1419617	1409837	rs2105277872	NC_000002.12:157778188:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.484G>A (p.Val162Met)	ACVR1	V162M	Progressive myositis ossificans|not provided	VCV000893616	2	158634702	2	157778190	893616	881269	rs201452185	NC_000002.12:157778189:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.483C>T (p.Asp161=)	ACVR1		not provided	VCV001904909	2	158634703	2	157778191	1904909	1961688		NC_000002.12:157778190:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 27, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.481G>A (p.Asp161Asn)	ACVR1	D161N	not provided	VCV003010298	2	158634705	2	157778193	3010298	3173188		NC_000002.12:157778192:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.478C>T (p.Arg160Ter)	ACVR1	R160*	not provided	VCV002036734	2	158634708	2	157778196	2036734	2101101		NC_000002.12:157778195:G:A	single nucleotide variant	nonsense	Uncertain significance	Oct 26, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.471C>T (p.Leu157=)	ACVR1		not provided	VCV003616212	2	158634715	2	157778203	3616212	3745890		NC_000002.12:157778202:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 17, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.469C>T (p.Leu157Phe)	ACVR1	L157F	not provided	VCV002716900	2	158634717	2	157778205	2716900	2876598		NC_000002.12:157778204:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.466C>T (p.Arg156Cys)	ACVR1	R156C	not provided	VCV002905384	2	158634720	2	157778208	2905384	3065489		NC_000002.12:157778207:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.455G>A (p.Arg152His)	ACVR1	R152H	not provided	VCV003022337	2	158634731	2	157778219	3022337	3179938		NC_000002.12:157778218:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.454C>T (p.Arg152Cys)	ACVR1	R152C	not provided	VCV002920390	2	158634732	2	157778220	2920390	3077829		NC_000002.12:157778219:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.450A>G (p.Lys150=)	ACVR1		Progressive myositis ossificans|not provided	VCV000331697	2	158634736	2	157778224	331697	282351	rs774878576	NC_000002.12:157778223:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jul 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.440G>A (p.Arg147Gln)	ACVR1	R147Q	Inborn genetic diseases|not provided	VCV001921502	2	158634746	2	157778234	1921502	1979118		NC_000002.12:157778233:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.431T>C (p.Val144Ala)	ACVR1	V144A	not provided	VCV002997411	2	158634755	2	157778243	2997411	3166756		NC_000002.12:157778242:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.422T>C (p.Leu141Pro)	ACVR1	L141P	not provided	VCV002093437	2	158634764	2	157778252	2093437	2156517		NC_000002.12:157778251:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.416C>T (p.Ala139Val)	ACVR1	A139V	Inborn genetic diseases	VCV003264915	2	158634770	2	157778258	3264915	3425053		NC_000002.12:157778257:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.412T>C (p.Leu138=)	ACVR1		not provided	VCV001964280	2	158634774	2	157778262	1964280	2020967		NC_000002.12:157778261:A:G	single nucleotide variant	synonymous variant	Benign	Dec 16, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.402A>G (p.Ala134=)	ACVR1		not provided	VCV002979530	2	158634784	2	157778272	2979530	3138122		NC_000002.12:157778271:T:C	single nucleotide variant	synonymous variant	Uncertain significance	Oct 14, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.400G>A (p.Ala134Thr)	ACVR1	A134T	not provided	VCV002957108	2	158634786	2	157778274	2957108	3125712		NC_000002.12:157778273:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.400G>T (p.Ala134Ser)	ACVR1	A134S	not provided	VCV002836751	2	158634786	2	157778274	2836751	3002523		NC_000002.12:157778273:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.399C>T (p.Phe133=)	ACVR1		not provided	VCV002720880	2	158634787	2	157778275	2720880	2891281		NC_000002.12:157778274:G:A	single nucleotide variant	synonymous variant	Likely benign	May 20, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.389C>G (p.Ser130Cys)	ACVR1	S130C	not provided	VCV002098938	2	158634797	2	157778285	2098938	2154252		NC_000002.12:157778284:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.365T>C (p.Leu122Ser)	ACVR1	L122S	not provided	VCV002852722	2	158634821	2	157778309	2852722	3006542		NC_000002.12:157778308:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.364T>C (p.Leu122=)	ACVR1		not provided	VCV003620060	2	158634822	2	157778310	3620060	3753900		NC_000002.12:157778309:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 12, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.362A>G (p.His121Arg)	ACVR1	H121R	Inborn genetic diseases	VCV002610528	2	158634824	2	157778312	2610528	2780249		NC_000002.12:157778311:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.332-12_361del	ACVR1		not provided	VCV002859288	2	158634825 - 158634866	2	157778313 - 157778354	2859288	3021902		NC_000002.12:157778312:GGAAATTCTGTGTTCCAGGGAAGGATTTTCCTGGAGTTGGAGGGAAA:GGAAA	Deletion	splice acceptor variant	Uncertain significance	Apr 26, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.361C>T (p.His121Tyr)	ACVR1	H121Y	not provided	VCV000871825	2	158634825	2	157778313	871825	859010	rs756858830	NC_000002.12:157778312:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.357T>C (p.Asn119=)	ACVR1		not provided	VCV001661365	2	158634829	2	157778317	1661365	1554617	rs147997205	NC_000002.12:157778316:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 19, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.343C>T (p.Pro115Ser)	ACVR1	P115S	not provided	VCV002754704	2	158634843	2	157778331	2754704	2914145		NC_000002.12:157778330:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.336A>C (p.Lys112Asn)	ACVR1	K112N	not provided	VCV001982283	2	158634850	2	157778338	1982283	2038843		NC_000002.12:157778337:T:G	single nucleotide variant	missense variant	Likely benign	Nov 22, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.332-4C>A	ACVR1		not provided	VCV002706703	2	158634858	2	157778346	2706703	2874157		NC_000002.12:157778345:G:T	single nucleotide variant	intron variant	Likely benign	Dec 31, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.332-10C>T	ACVR1		not provided	VCV001922471	2	158634864	2	157778352	1922471	1972312		NC_000002.12:157778351:G:A	single nucleotide variant	intron variant	Likely benign	Mar 2, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.332-15T>C	ACVR1		not provided	VCV003618492	2	158634869	2	157778357	3618492	3750167		NC_000002.12:157778356:A:G	single nucleotide variant	intron variant	Likely benign	Jun 3, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.332-20C>T	ACVR1		not provided	VCV001544863	2	158634874	2	157778362	1544863	1644269	rs1686374523	NC_000002.12:157778361:G:A	single nucleotide variant	intron variant	Likely benign	Jul 12, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.332-197T>C	ACVR1		not provided	VCV001229192	2	158635051	2	157778539	1229192	1221742	rs1146038	NC_000002.12:157778538:A:G	single nucleotide variant	intron variant	Benign	Sep 4, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.331+16T>C	ACVR1		not provided	VCV001577304	2	158636833	2	157780321	1577304	1553340	rs2105280861	NC_000002.12:157780320:A:G	single nucleotide variant	intron variant	Likely benign	Aug 11, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.331+15T>C	ACVR1		not provided	VCV001604232	2	158636834	2	157780322	1604232	1558746	rs752458725	NC_000002.12:157780321:A:G	single nucleotide variant	intron variant	Likely benign	Jul 26, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.331+12C>A	ACVR1		not provided	VCV001557543	2	158636837	2	157780325	1557543	1627986	rs760568233	NC_000002.12:157780324:G:T	single nucleotide variant	intron variant	Likely benign	Aug 2, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.331+11A>G	ACVR1		not provided	VCV002135180	2	158636838	2	157780326	2135180	2190588		NC_000002.12:157780325:T:C	single nucleotide variant	intron variant	Likely benign	May 7, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.331+10G>A	ACVR1		not provided	VCV002193322	2	158636839	2	157780327	2193322	1928999		NC_000002.12:157780326:C:T	single nucleotide variant	intron variant	Likely benign	Aug 14, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.331+7A>G	ACVR1		not provided	VCV002715161	2	158636842	2	157780330	2715161	2876159		NC_000002.12:157780329:T:C	single nucleotide variant	intron variant	Likely benign	Jan 8, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.324C>T (p.Pro108=)	ACVR1		not provided	VCV000738373	2	158636856	2	157780344	738373	746848	rs1574056161	NC_000002.12:157780343:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 20, 2017	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.318G>C (p.Gln106His)	ACVR1	Q106H	Inborn genetic diseases	VCV003485379	2	158636862	2	157780350	3485379	3640955		NC_000002.12:157780349:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.314C>T (p.Ala105Val)	ACVR1	A105V	not provided	VCV002126003	2	158636866	2	157780354	2126003	2185172		NC_000002.12:157780353:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.312G>A (p.Thr104=)	ACVR1		not provided	VCV002068807	2	158636868	2	157780356	2068807	2122778		NC_000002.12:157780355:C:T	single nucleotide variant	synonymous variant	Benign	Aug 30, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.311C>T (p.Thr104Met)	ACVR1	T104M	not provided	VCV001897482	2	158636869	2	157780357	1897482	1962909		NC_000002.12:157780356:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.287G>A (p.Gly96Glu)	ACVR1	G96E	not provided	VCV002791329	2	158636893	2	157780381	2791329	2953760		NC_000002.12:157780380:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.276G>A (p.Glu92=)	ACVR1		not provided	VCV002890298	2	158636904	2	157780392	2890298	3051739		NC_000002.12:157780391:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 31, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.274G>A (p.Glu92Lys)	ACVR1	E92K	not provided	VCV003021814	2	158636906	2	157780394	3021814	3183374		NC_000002.12:157780393:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.271G>A (p.Val91Met)	ACVR1	V91M	not specified	VCV002691494	2	158636909	2	157780397	2691494	2852517		NC_000002.12:157780396:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.270C>T (p.Ala90=)	ACVR1		not specified|Progressive myositis ossificans|not provided	VCV000257464	2	158636910	2	157780398	257464	250304	rs2227861	NC_000002.12:157780397:G:A	single nucleotide variant	synonymous variant	Benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.259C>A (p.Pro87Thr)	ACVR1	P87T	Inborn genetic diseases	VCV002370050	2	158636921	2	157780409	2370050	2357995		NC_000002.12:157780408:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.255G>A (p.Pro85=)	ACVR1		not provided	VCV002725644	2	158636925	2	157780413	2725644	2882262		NC_000002.12:157780412:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 19, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.252G>A (p.Pro84=)	ACVR1		not provided	VCV001590163	2	158636928	2	157780416	1590163	1576708	rs201408818	NC_000002.12:157780415:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 19, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.251C>A (p.Pro84Gln)	ACVR1	P84Q	not provided	VCV003000874	2	158636929	2	157780417	3000874	3167627		NC_000002.12:157780416:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.251C>T (p.Pro84Leu)	ACVR1	P84L	Inborn genetic diseases|not provided	VCV001413590	2	158636929	2	157780417	1413590	1361493	rs775537696	NC_000002.12:157780416:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2021	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.248C>A (p.Thr83Asn)	ACVR1	T83N	not provided	VCV002974846	2	158636932	2	157780420	2974846	3133498		NC_000002.12:157780419:G:T	single nucleotide variant	missense variant	Uncertain significance	May 12, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.236T>C (p.Met79Thr)	ACVR1	M79T	not provided	VCV002693497	2	158636944	2	157780432	2693497	2853630		NC_000002.12:157780431:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.211T>C (p.Phe71Leu)	ACVR1	F71L	Inborn genetic diseases	VCV002277547	2	158636969	2	157780457	2277547	2269958		NC_000002.12:157780456:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.198C>T (p.Tyr66=)	ACVR1		not provided	VCV002187964	2	158636982	2	157780470	2187964	1921878		NC_000002.12:157780469:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.193G>A (p.Val65Ile)	ACVR1	V65I	not provided	VCV001930810	2	158636987	2	157780475	1930810	1988405		NC_000002.12:157780474:C:T	single nucleotide variant	missense variant	Benign	Aug 10, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.192C>T (p.His64=)	ACVR1		not provided	VCV001663239	2	158636988	2	157780476	1663239	1609156	rs543026651	NC_000002.12:157780475:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 9, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.188T>C (p.Phe63Ser)	ACVR1	F63S	not provided	VCV002132896	2	158636992	2	157780480	2132896	2191735		NC_000002.12:157780479:A:G	single nucleotide variant	missense variant	Likely benign	Jul 19, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.181G>A (p.Asp61Asn)	ACVR1	D61N	not provided	VCV001353791	2	158636999	2	157780487	1353791	1495910	rs772534199	NC_000002.12:157780486:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 4, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.180C>T (p.Asn60=)	ACVR1		not provided	VCV001547918	2	158637000	2	157780488	1547918	1537736	rs55728089	NC_000002.12:157780487:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.170T>C (p.Leu57Pro)	ACVR1	L57P	not provided	VCV002076768	2	158637010	2	157780498	2076768	2134589		NC_000002.12:157780497:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.147A>G (p.Glu49=)	ACVR1		not provided	VCV001561677	2	158637033	2	157780521	1561677	1608216	rs2105281306	NC_000002.12:157780520:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 6, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.141C>G (p.His47Gln)	ACVR1	H47Q	Progressive myositis ossificans|not provided	VCV000331698	2	158637039	2	157780527	331698	284599	rs34056189	NC_000002.12:157780526:G:C	single nucleotide variant	missense variant	Benign/Likely benign	Jan 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.139C>G (p.His47Asp)	ACVR1	H47D	not provided	VCV003014545	2	158637041	2	157780529	3014545	3170981		NC_000002.12:157780528:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.127G>A (p.Gly43Ser)	ACVR1	G43S	not provided	VCV000744802	2	158637053	2	157780541	744802	746849	rs112489929	NC_000002.12:157780540:C:T	single nucleotide variant	missense variant	Likely benign	Dec 13, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.126C>T (p.Cys42=)	ACVR1		not provided|Progressive myositis ossificans	VCV000893617	2	158637054	2	157780542	893617	881270	rs748424210	NC_000002.12:157780541:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Sep 10, 2023	criteria provided, conflicting classifications							
NM_001111067.4(ACVR1):c.122C>T (p.Ser41Phe)	ACVR1	S41F	Inborn genetic diseases|Progressive myositis ossificans|not provided	VCV000893905	2	158637058	2	157780546	893905	881271	rs55957214	NC_000002.12:157780545:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.116G>T (p.Gly39Val)	ACVR1	G39V	not provided|Inborn genetic diseases	VCV002711407	2	158637064	2	157780552	2711407	2878859		NC_000002.12:157780551:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.115G>A (p.Gly39Ser)	ACVR1	G39S	not provided	VCV002651445	2	158637065	2	157780553	2651445	2819121		NC_000002.12:157780552:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 5, 2023	criteria provided, conflicting classifications							
NM_001111067.4(ACVR1):c.107T>C (p.Val36Ala)	ACVR1	V36A	not provided	VCV002723581	2	158637073	2	157780561	2723581	2881494		NC_000002.12:157780560:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.106G>C (p.Val36Leu)	ACVR1	V36L	ACVR1-related disorder	VCV003061425	2	158637074	2	157780562	3061425	3193930		NC_000002.12:157780561:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	no assertion criteria provided							
NM_001111067.4(ACVR1):c.100_101del (p.Met34fs)	ACVR1	M34fs	not provided	VCV003019117	2	158637079 - 158637080	2	157780567 - 157780568	3019117	3175481		NC_000002.12:157780566:AT:	Deletion	frameshift variant	Uncertain significance	Jun 30, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.99C>A (p.Tyr33Ter)	ACVR1	Y33*	not provided	VCV001502808	2	158637081	2	157780569	1502808	1404401	rs201453468	NC_000002.12:157780568:G:T	single nucleotide variant	nonsense	Uncertain significance	Jun 8, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.99C>T (p.Tyr33=)	ACVR1		not provided|Progressive myositis ossificans	VCV000331699	2	158637081	2	157780569	331699	285041	rs201453468	NC_000002.12:157780568:G:A	single nucleotide variant	synonymous variant	Benign	Dec 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.92A>G (p.Lys31Arg)	ACVR1	K31R	not provided	VCV001947179	2	158637088	2	157780576	1947179	1996142		NC_000002.12:157780575:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.84C>T (p.Val28=)	ACVR1		not provided	VCV002971240	2	158637096	2	157780584	2971240	3132483		NC_000002.12:157780583:G:A	single nucleotide variant	synonymous variant	Likely benign	May 9, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.79A>G (p.Lys27Glu)	ACVR1	K27E	not provided	VCV002862709	2	158637101	2	157780589	2862709	3022758		NC_000002.12:157780588:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.76C>T (p.Pro26Ser)	ACVR1	P26S	not provided	VCV001421920	2	158637104	2	157780592	1421920	1337534	rs377197386	NC_000002.12:157780591:G:A	single nucleotide variant	missense variant	Benign	Jun 23, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.68-6T>C	ACVR1		not provided	VCV000745564	2	158637118	2	157780606	745564	759134	rs1574056817	NC_000002.12:157780605:A:G	single nucleotide variant	intron variant	Likely benign	May 9, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.68-8C>T	ACVR1		not provided	VCV003608207	2	158637120	2	157780608	3608207	3740485		NC_000002.12:157780607:G:A	single nucleotide variant	intron variant	Likely benign	Feb 25, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.68-9C>G	ACVR1		not provided	VCV002826703	2	158637121	2	157780609	2826703	2986505		NC_000002.12:157780608:G:C	single nucleotide variant	intron variant	Likely benign	Jan 31, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.68-11C>T	ACVR1		not provided	VCV003001217	2	158637123	2	157780611	3001217	3164045		NC_000002.12:157780610:G:A	single nucleotide variant	intron variant	Likely benign	Dec 25, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.68-38dup	ACVR1		not provided	VCV001196031	2	158637136 - 158637137	2	157780624 - 157780625	1196031	1186282	rs77640967	NC_000002.12:157780624:AAAAAAAAAAAAAA:AAAAAAAAAAAAAAA	Duplication	intron variant	Likely benign	Dec 1, 2020	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.68-26_68-25del	ACVR1		not provided	VCV001706968	2	158637137 - 158637138	2	157780625 - 157780626	1706968	1705279		NC_000002.12:157780624:AAAAAAAAAAAAAA:AAAAAAAAAAAA	Deletion	intron variant	Likely benign	Nov 20, 2020	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.68-25del	ACVR1		not provided	VCV001298221	2	158637137	2	157780625	1298221	1288006	rs77640967	NC_000002.12:157780624:AAAAAAAAAAAAAA:AAAAAAAAAAAAA	Deletion	intron variant	Benign	Jun 29, 2020	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.68-25T>C	ACVR1		not provided|Progressive myositis ossificans	VCV001188893	2	158637137	2	157780625	1188893	1178866	rs1866885	NC_000002.12:157780624:A:G	single nucleotide variant	intron variant	Benign	Jul 14, 2021	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.68-26T>C	ACVR1		not provided	VCV001257888	2	158637138	2	157780626	1257888	1249937	rs35392775	NC_000002.12:157780625:A:G	single nucleotide variant	intron variant	Benign	May 8, 2021	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.68-236del	ACVR1		not provided	VCV001266960	2	158637348	2	157780836	1266960	1254283	rs147945266	NC_000002.12:157780835:A:	Deletion	intron variant	Benign	Dec 1, 2020	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.68-321C>T	ACVR1		not provided	VCV001282440	2	158637433	2	157780921	1282440	1272294	rs73023334	NC_000002.12:157780920:G:A	single nucleotide variant	intron variant	Benign	Jun 18, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.67+192T>A	ACVR1		not provided	VCV001263337	2	158655747	2	157799235	1263337	1251955	rs72923499	NC_000002.12:157799234:A:T	single nucleotide variant	intron variant	Benign	May 10, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.67+45_67+46dup	ACVR1		not provided	VCV001235885	2	158655883 - 158655884	2	157799371 - 157799372	1235885	1225005	rs3030646	NC_000002.12:157799371:AAAAAAAAAAA:AAAAAAAAAAAAA	Duplication	intron variant	Benign	Jun 29, 2020	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.67+45_67+47dup	ACVR1		not provided	VCV001220125	2	158655883 - 158655884	2	157799371 - 157799372	1220125	1210101	rs3030646	NC_000002.12:157799371:AAAAAAAAAAA:AAAAAAAAAAAAAA	Duplication	intron variant	Likely benign	Jun 29, 2020	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.67+45dup	ACVR1		not provided	VCV001183474	2	158655883 - 158655884	2	157799371 - 157799372	1183474	1170813	rs3030646	NC_000002.12:157799371:AAAAAAAAAAA:AAAAAAAAAAAA	Duplication	intron variant	Benign	Sep 15, 2020	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.67+10_67+11del	ACVR1		not provided	VCV002815660	2	158655928 - 158655929	2	157799416 - 157799417	2815660	2966496		NC_000002.12:157799415:GAG:G	Deletion	intron variant	Likely benign	Nov 23, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.67+9C>T	ACVR1		not provided	VCV001601849	2	158655930	2	157799418	1601849	1523792	rs1559063995	NC_000002.12:157799417:G:A	single nucleotide variant	intron variant	Likely benign	Aug 16, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.67+4A>G	ACVR1		not provided	VCV003003692	2	158655935	2	157799423	3003692	3161398		NC_000002.12:157799422:T:C	single nucleotide variant	intron variant	Uncertain significance	Nov 14, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.67+3A>T	ACVR1		not provided	VCV002133538	2	158655936	2	157799424	2133538	2190227		NC_000002.12:157799423:T:A	single nucleotide variant	intron variant	Uncertain significance	May 5, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.64G>C (p.Glu22Gln)	ACVR1	E22Q	not provided	VCV002873696	2	158655942	2	157799430	2873696	3032411		NC_000002.12:157799429:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.55C>T (p.Pro19Ser)	ACVR1	P19S	not provided	VCV001922454	2	158655951	2	157799439	1922454	1972295		NC_000002.12:157799438:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.52T>A (p.Ser18Thr)	ACVR1	S18T	not provided	VCV002885971	2	158655954	2	157799442	2885971	3043976		NC_000002.12:157799441:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.44C>G (p.Ala15Gly)	ACVR1	A15G	Progressive myositis ossificans|not specified|not provided	VCV000257465	2	158655962	2	157799450	257465	250305	rs13406336	NC_000002.12:157799449:G:C	single nucleotide variant	missense variant	Benign/Likely benign	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.40A>G (p.Ile14Val)	ACVR1	I14V	not provided	VCV002111700	2	158655966	2	157799454	2111700	2160521		NC_000002.12:157799453:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2022	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.36C>G (p.Ile12Met)	ACVR1	I12M	Inborn genetic diseases	VCV003485360	2	158655970	2	157799458	3485360	3640936		NC_000002.12:157799457:G:C	single nucleotide variant	missense variant	Likely benign	Jul 14, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.34A>G (p.Ile12Val)	ACVR1	I12V	not provided	VCV003021718	2	158655972	2	157799460	3021718	3183278		NC_000002.12:157799459:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 4, 2024	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.27T>C (p.Pro9=)	ACVR1		not provided	VCV000749595	2	158655979	2	157799467	749595	746850	rs368327202	NC_000002.12:157799466:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 17, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.25C>T (p.Pro9Ser)	ACVR1	P9S	Inborn genetic diseases|not provided	VCV003142973	2	158655981	2	157799469	3142973	3296965		NC_000002.12:157799468:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_001111067.4(ACVR1):c.11G>A (p.Gly4Glu)	ACVR1	G4E	not provided	VCV001611825	2	158655995	2	157799483	1611825	1552341	rs1203606345	NC_000002.12:157799482:C:T	single nucleotide variant	missense variant	Likely benign	Oct 13, 2021	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.1A>G (p.Met1Val)	ACVR1	M1V	not provided	VCV002156489	2	158656005	2	157799493	2156489	1886160		NC_000002.12:157799492:T:C	single nucleotide variant	missense variant|initiator_codon_variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.-13A>G	ACVR1		Progressive myositis ossificans	VCV000331700	2	158674902	2	157818390	331700	285044	rs113455580	NC_000002.12:157818389:T:C	single nucleotide variant	5 prime UTR variant	Benign	Jan 12, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.-53C>T	ACVR1		Progressive myositis ossificans	VCV000331701	2	158674942	2	157818430	331701	284600	rs73966130	NC_000002.12:157818429:G:A	single nucleotide variant	5 prime UTR variant	Benign	Jan 12, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.-55C>T	ACVR1		Progressive myositis ossificans	VCV000331702	2	158674944	2	157818432	331702	284603	rs375327491	NC_000002.12:157818431:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.-99G>A	ACVR1		Progressive myositis ossificans	VCV000893906	2	158674988	2	157818476	893906	881272	rs939671710	NC_000002.12:157818475:C:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.-182-10C>T	ACVR1		Progressive myositis ossificans	VCV000893907	2	158675081	2	157818569	893907	882818	rs186304210	NC_000002.12:157818568:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.-183+919A>G	ACVR1		Progressive myositis ossificans	VCV000331703	2	158731389	2	157874877	331703	283020	rs374473767	NC_000002.12:157874876:T:C	single nucleotide variant	5 prime UTR variant|intron variant	Benign	Jan 12, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.-183+822G>A	ACVR1		Progressive myositis ossificans	VCV000894297	2	158731486	2	157874974	894297	881273	rs1166307603	NC_000002.12:157874973:C:T	single nucleotide variant	5 prime UTR variant|intron variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_001111067.4(ACVR1):c.-183+673C>G	ACVR1		Progressive myositis ossificans	VCV000894298	2	158731635	2	157875123	894298	882819	rs1379620426	NC_000002.12:157875122:G:C	single nucleotide variant	intron variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
GRCh37/hg19 2q23.3-24.2(chr2:152709810-160343075)x3	ACVR1|ACVR1C|ARL6IP6|BAZ2B|CACNB4|CCDC148|CYTIP|DAPL1|ERMN|FMNL2|GALNT13|GALNT5|GPD2|KCNJ3|NR4A2|PKP4|PRPF40A|RPRM|STAM2|TANC1|UPP2|WDSUB1		not provided	VCV003391990	2	152709810 - 160343075			3391990	3551070			copy number gain		Uncertain significance	Apr 20, 2024	criteria provided, single submitter							
GRCh37/hg19 2q24.1-24.3(chr2:157718631-165360287)x1	CCDC148|CD302|CYTIP|FIGN|GALNT5|GCA|GCG|GRB14|IFIH1|ITGB6|DPP4|ERMN|FAP|DAPL1|ACVR1|ACVR1C|BAZ2B|KCNH7|LY75|LY75-CD302|MARCHF7|PKP4|PLA2R1|PSMD14|RBMS1|SLC4A10|TANC1|TANK|TBR1|UPP2|WDSUB1		not specified	VCV003062503	2	157718631 - 165360287			3062503	3222727			copy number loss		Pathogenic		criteria provided, single submitter							
GRCh37/hg19 2p25.3-q37.3(chr2:1-243199373)	ACMSD|ALLC|ARHGAP15|ARHGAP25|BOK|CASP8|CERKL|CERS6|CFAP210|COA5|CYBRD1|CYP1B1|DNAH6|DNAH7|EIF2AK3|FAM124B|FAM136A|FAM161A|FAM168B|FOXD4L1|FOXI3|FOXN2|FRZB|GPC1|HOXD11|HOXD12|HOXD13|IL36A|IL36B|KCNG3|LINC02898|LINC03124|MARCHF4|MARCHF7|MOGAT1|NAB1|NABP1|NOP58|NOSTRIN|NOTO|PDCD1|PDCL3|POLR1A|POLR1B|PSMD14|PSME4|REG3A|RPE|SFTPB|SFXN5|SGO2|SGPP2|SOCS5|STK36|STK39|STON1|THAP4|TRAPPC12|TRIB2|UGT1A10|UGT1A3|WDR43|WDR54|WDR75|WIPF1|XDH|XIRP2|XPO1|XRCC5|YIPF4|YPEL5|YWHAQ|UGT1A5|UGT1A6|WNT10A|WNT6|WDSUB1|UGT1A4|UGT1A9|UNC50|UNC80|TSN|TSPYL6|TTC21B|TTC27|TTC31|TTC32|TTC7A|TRIM54|TRIP12|UGT1A7|UGT1A8|UPP2|USP34|USP37|USP39|THNSL2|THSD7B|THUMPD2|TIA1|TIGD1|TLK1|TLX2|TM4SF20|TMBIM1|TMEFF2|TMEM177|TMEM178A|TMEM18|TMEM182|USP40|STRADB|STRN|SUCLG1|SULT1C2|SULT1C3|SULT1C4|SULT6B1|SUMO1|SUPT7L|TACR1|TRIM43|TRIM43B|STON1-GTF2A1L|STPG4|TRMT61B|TRPM8|TSGA10|SP110|SP140|SP140L|SPAG16|SPEG|SPHKAP|SPMIP9|SPR|SLC11A1|SLC16A14|SLC19A3|SLC23A3|SLC39A10|SLC3A1|SLC40A1|SLC1A4|SLC20A1|SH2D6|SH3BP4|SH3YL1|SIX2|SIX3|SP3|SP5|SP9|SPOPL|SPP2|RPIA|RPL31|RPL37A|RPRM|RPS27A|RSAD2|RTKN|RTN4|RTP5|RGPD1|RESP18|RETREG2|SANBR|RPS7|RRM2|RUFY4|SAG|REG3G|RGPD2|RGPD3|RGPD4|RGPD5|RGPD6|R3HDM1|RAB10|RAB11FIP5|RAB17|RAB1A|RAB3GAP1|PTMA|PTPN18|PTPN4|PTPRN|PTRHD1|REL|RETSAT|REV1|RFTN2|RFX8|PTCD3|PTH2R|POTEI|POTEJ|PPP1R1C|PPP1R21|PPP1R7|PPP3R1|POMC|POTEF|PUM2|PUS10|PXDN|PDE11A|PDK1|PECR|PELI1|PER2|PEX13|PFN4|PGAP1|PHOSPHO2|PID1|PIGF|PIKFYVE|PDE1A|PDE6D|PDIA6|QPCT|POLR2D|NPAS2|NPHP1|NT5DC4|NTSR2|NUP35|NXPH2|NYAP2|OBSL1|ODC1|OLA1|NCKAP5|NCL|NCOA1|NPPC|NT5C1B-RDH14|POTEE|NAGK|NAT8|NAT8B|NBAS|NBEAL1|MRPL53|MPHOSPH10|MPP4|MPV17|NCAPH|NDUFA10|NDUFAF7|NCK2|NCKAP1|MOGS|MORN2|MREG|METTL21A|METTL5|METTL8|MFF|MEIS1|MEMO1|MERTK|METAP1D|MROH2A|MRPL19|MRPL30|MRPL33|MRPL35|MRPL44|LONRF2|LRP1B|LRP2|LRPPRC|LRRTM4|LNPK|LOXL3|LPIN1|LRATD1|LRRFIP1|LRRTM1|LTBP1|LY75|MARCO|MARS2|MAT2A|MATN3|KCNH7|KCNK12|KCNK3|KCNS3|KCTD18|KDM3A|KHK|KIDINS220|KLHL30|KLHL41|KCNIP3|KCNJ13|KCNJ3|MDH1B|LIPT1|LMAN2L|IL36G|IL36RN|IL37|ILKAP|IMMT|IMP4|ING5|INHA|INHBB|HYCC2|IAH1|ICA1L|ID2|IDH1|IFIH1|HOXD3|ICOS|INO80B|INO80D|INPP1|INPP4A|GTF3C2|GTF3C3|GPR55|GPR75|GPR75-ASB3|GULP1|GRHL1|GTDC1|GTF2A1L|GRB14|GREB1|HOXD4|HOXD8|GDF7|HTR2B|HTRA2|GPD2|GPN1|FSIP2|FTCDNL1|FZD5|FZD7|G6PC2|GAD1|GAL3ST2|GALM|GALNT13|GALNT14|GALNT3|FSHR|FASTKD2|FAM98A|FANCL|FAP|FAM171B|FAM178B|FAM228A|FAM228B|FARP2|FARSB|FASTKD1|ELMOD3|EMILIN1|EML4|EPB41L5|EIF2B4|EIF4E2|EIF5B|EIPR1|EML6|EMX1|EN1|EPAS1|EPC2|DUSP11|DUSP19|DNAJB2|DNAJC10|DNAJC27|DNAJB3|DNAJC5G|DNER|DPY30|DPYSL5|DQX1|DRC1|DTNB|DTYMK|CYP20A1|CYP26B1|D2HGDH|DARS1|DAW1|CYRIA|CYS1|CYTIP|DAPL1|CYP27A1|CYP27C1|COLEC11|COMMD1|COPS7B|COPS8|COQ10B|COX5B|COPS9|COX7A2L|CPO|CPS1|CPSF3|CRACDL|COBLL1|CHRND|CHRNG|CHST10|CIMIP2C|CIMIP5|CIAO1|CIB4|CHMP3|CHN1|CFAP36|CFAP65|CHPF|CHRNA1|CCDC138|CCDC140|CCDC85A|CCDC88A|CCDC93|CCL20|CCNT2|CCDC141|CCDC142|CCDC148|CCDC150|CCDC74A|CCDC74B|CATIP|CAVIN2|CCDC115|CCDC121|C2orf66|C2orf68|C2orf69|C2orf72|C2orf74|BUB1|BZW1|C1D|BOLA3|BOLL|C1QL2|C2CD6|C2orf15|C2orf42|C2orf48|C2orf49|ASNSD1|ASPRV1|ATIC|ASTL|ARHGEF33|ARPC2|ASAP2|ASB1|ASB18|ASB3|ASIC4|ALPG|ALPI|ALMS1|ALPP|ALS2|AMER3|AMMECR1L|ANAPC1|ANKAR|ACTR1B|ACOXL|ACTR2|ACTR3|ACP1|ACVR1|ACSL3|ACTG2|ACVR1C|AAK1|AAMP|ABCA12|ABCB11|ABCB6|ABCG5|ABCG8|ABHD1|ABI2|ACADL|ACKR3|ACVR2A|ACYP2|ADAM17|ADAM23|ADCY3|ADD2|ADGRF3|ADI1|ADRA2B|AFF3|AFTPH|AGAP1|AGBL5|AGFG1|AGPS|AGXT|ALK|ALKAL2|ANKMY1|ANKRD23|ANKRD36|ANKRD36B|ANKRD36C|ANKRD39|ANKRD44|ANKRD53|ANKZF1|ANO7|ANTXR1|ANXA4|AOX1|AP1S3|APLF|APOB|AQP12A|AQP12B|ARHGEF4|ARID5A|ARL4C|ARL5A|ARL6IP6|ARMC9|ASXL2|ATAD2B|ATF2|ATG16L1|ATG4B|ATG9A|ATL2|ATOH8|ATP5MC3|ATP6V1B1|ATP6V1C2|ATP6V1E2|ATRAID|AUP1|B3GALT1|B3GNT2|B3GNT7|BABAM2|BARD1|BAZ2B|BBS5|BCL11A|BCL2L11|BCS1L|BCYRN1|BIN1|BIRC6|BMP10|BMPR2|C2orf76|C2orf78|C2orf80|C2orf81|C2orf83|C2orf88|CAB39|CACNB4|CAD|CALCRL|CALM2|CAMKMT|CAPG|CAPN10|CAPN13|CAPN14|CARF|CASP10|CCNYL1|CCT4|CCT7|CD207|CD28|CD302|CD8A|CD8B|CDC42EP3|CDCA7|CDK15|CDK5R2|CDKL4|CDRT15P3|CEBPZ|CENPA|CENPO|CEP68|CFC1|CFC1B|CFLAR|CGREF1|CHAC2|CHCHD5|CIMIP6|CIR1|CKAP2L|CLASP1|CLEC4F|CLHC1|CLIP4|CLK1|CMKLR2|CMPK2|CNGA3|CNNM3|CNNM4|CNOT11|CNOT9|CNPPD1|CNRIP1|CNTNAP5|COL3A1|COL4A3|COL4A4|COL5A2|COL6A3|CREB1|CREG2|CRIM1|CRIPT|CRYBA2|CRYGA|CRYGB|CRYGC|CRYGD|CSRNP3|CTDSP1|CTLA4|CTNNA2|CUL3|CWC22|CXCR1|CXCR2|CXCR4|DBI|DCAF17|DCDC2C|DCTN1|DDX1|DDX18|DES|DGKD|DGUOK|DHRS9|DHX57|DIRC1|DIRC3|DIS3L2|DLX1|DLX2|DNAAF10|DNMT3A|DNPEP|DOCK10|DOK1|DPP10|DPP4|DUSP2|DUSP28|DYNC1I2|DYNC2LI1|DYSF|DYTN|E2F6|ECEL1|ECRG4|EDAR|EEF1B2|EFEMP1|EFHD1|EFR3B|EGR4|EHBP1|EHD3|EIF2AK2|EPCAM|EPHA4|ERBB4|ERCC3|ERFE|ERICH2|ERLEC1|ERMN|ESPNL|ETAA1|EVA1A|EVX2|EXOC6B|FABP1|FAHD2A|FAHD2B|FAM110C|FAM117B|FBLN7|FBXO11|FBXO36|FBXO41|FBXO48|FER1L5|FEV|FEZ2|FHL2|FIGLA|FIGN|FKBP1B|FKBP7|FLACC1|FMNL2|FN1|FNDC4|FOSL2|GALNT5|GAREM2|GBX2|GCA|GCC2|GCKR|GCFC2|GCG|GEMIN6|GEN1|GFPT1|GGCX|GIGYF2|GKN1|GKN2|GLB1L|GLI2|GLS|GMCL1|GMPPA|GNLY|GORASP2|GPAT2|GPATCH11|GPBAR1|GPR148|GPR155|GPR17|GPR35|GPR39|GPR45|GYPC|HAAO|HADHA|HADHB|HAT1|HDAC4|HDLBP|HEATR5B|HECW2|HES6|HIBCH|HJURP|HK2|HNMT|HNRNPA3|HNRNPLL|HOXD1|HOXD10|HOXD9|HPCAL1|HS1BP3|HS6ST1|HSPD1|HSPE1|IFT172|IFT70A|IFT70B|IGFBP2|IGFBP5|IGKC|IHH|IKZF2|IL18R1|IL18RAP|IL1A|IL1B|IL1F10|IL1R1|IL1R2|IL1RL1|IL1RL2|IL1RN|INSIG2|IQCA1|IRS1|ITGA4|ITGA6|ITGAV|ITGB1BP1|ITGB6|ITM2C|ITPRID2|ITPRIPL1|ITSN2|IWS1|KANSL1L|KANSL3|KCMF1|KCNE4|KCNF1|KIF1A|KIF3C|KLF11|KLF7|KLHL23|KLHL29|KRCC1|KRTCAP3|KYNU|LANCL1|LAPTM4A|LBH|LBX2|LCLAT1|LCT|LDAH|LGALSL|LHCGR|LIMS1|LIMS2|LIMS3|LIMS4|LINC00570|LINC01873|LY75-CD302|LYG1|LYG2|LYPD1|LYPD6|LYPD6B|M1AP|MAB21L4|MAIP1|MAL|MALL|MAP2|MAP3K19|MAP3K2|MAP3K20|MAP4K3|MAP4K4|MAPRE3|MBD5|MBOAT2|MCEE|MCFD2|MCM6|MDH1|MFSD2B|MFSD6|MFSD9|MGAT4A|MGAT5|MIR10B|MIR1258|MIR128-1|MIR149|MIR216A|MIR217|MIR26B|MIR375|MITD1|MLPH|MMADHC|MOB1A|MOB4|MRPS5|MRPS9|MSGN1|MSH2|MSH2-OT1|MSH6|MSTN|MTA3|MTERF4|MTHFD2|MTIF2|MTX2|MXD1|MYCN|MYCNOS|MYL1|MYO1B|MYO3B|MYO7B|MYT1L|MZT2A|MZT2B|NDUFB3|NDUFS1|NEB|NEMP2|NEU2|NEU4|NEUROD1|NFE2L2|NFU1|NGEF|NHEJ1|NIF3L1|NIFK|NLRC4|NMI|NMS|NMUR1|NOL10|NR4A2|NRBP1|NRP2|NRXN1|NT5C1B|OR6B2|OR6B3|ORC2|ORC4|ORMDL1|OSBPL6|OSGEPL1|OSR1|OST4|OTOF|OTOS|OTX1|OXER1|PAIP2B|PAPOLG|PARD3B|PASK|PAX3|PAX8|PCARE|PCBP1|PCGEM1|PCGF1|PCYOX1|PJVK|PKDCC|PKP4|PLA2R1|PLB1|PLCD4|PLCL1|PLEK|PLEKHA3|PLEKHB2|PLEKHH2|PLEKHM3|PLGLB1|PMS1|PNKD|PNO1|PNPT1|POLE4|POU3F3|PPIG|PPIL3|PPM1B|PPM1G|PPP1CB|PPP4R3B|PRADC1|PREB|PREPL|PRKAG3|PRKCE|PRKD3|PRKRA|PRLH|PROC|PROKR1|PROM2|PRPF40A|PRR21|PRR30|PRSS56|PSD4|PSMD1|RAB6C|RABL2A|RAD51AP2|RALB|RAMP1|RANBP2|RAPGEF4|RAPH1|RASGRP3|RBKS|RBM43|RBM44|RBM45|RBMS1|RDH14|REEP1|REG1A|REG1B|RGPD8|RHBDD1|RHOB|RHOQ|RIF1|RMDN2|RMND5A|RNASEH1|RND3|RNF103|RNF103-CHMP3|RNF144A|RNF149|RNF181|RNF25|RNPEPL1|RNU4ATAC|ROCK2|SAP130|SATB2|SCG2|SCLY|SCN1A|SCN2A|SCN3A|SCN7A|SCN9A|SCRN3|SCTR|SDC1|SELENOI|SEMA4C|SEMA4F|SEPTIN10|SEPTIN2|SERPINE2|SERTAD2|SESTD1|SF3B1|SF3B6|SFT2D3|SLC25A12|SLC30A3|SLC30A6|SLC35F5|SLC35F6|SLC38A11|SLC4A10|SLC4A1AP|SLC4A3|SLC4A5|SLC5A6|SLC5A7|SLC66A3|SLC8A1|SLC9A2|SLC9A4|SMARCAL1|SMC6|SMPD4|SMYD1|SMYD5|SNED1|SNORC|SNORD20|SNORD82|SNRNP200|SNRNP27|SNRPG|SNTG2|SNX17|SOS1|SOS1-IT1|SOWAHC|SOX11|SP100|SPAST|SPATA3|SPATA31H1|SPATS2L|SPC25|SPDYA|SPRED2|SPTBN1|SRBD1|SRD5A2|SRSF7|SSB|ST3GAL5|ST6GAL2|STAM2|STAMBP|STARD7|STAT1|STAT4|STEAP3|STK11IP|STK16|STK17B|STK25|TAF1B|TANC1|TANK|TBC1D8|TBR1|TCF23|TCF7L1|TDRD15|TEKT4|TET3|TEX261|TEX44|TFCP2L1|TFPI|TGFA|TGFBRAP1|TGOLN2|THADA|TMEM127|TMEM131|TMEM150A|TMEM163|TMEM169|TMEM17|TMEM185B|TMEM198|TMEM214|TMEM237|TMEM247|TMEM37|TMEM87B|TMSB10|TNFAIP6|TNP1|TNS1|TOGARAM2|TP53I3|TPO|TPRKB|TRABD2A|TRAF3IP1|TRAK2|TTL|TTLL4|TTN|TUBA3D|TUBA3E|TUBA4A|TWIST2|TXNDC9|TYW5|UBE2E3|UBE2F|UBR3|UBXN2A|UBXN4|UCN|UGGT1|UGP2|UGT1A1|UXS1|VAMP5|VAMP8|VAX2|VIL1|VIT|VPS54|VRK2|VSNL1|VWA3B|VWC2L|WBP1|WDCP|WDFY1|WDPCP|WDR12|WDR33|WDR35|ZAP70|ZC3H15|ZC3H6|ZC3H8|ZDBF2|ZNF512|ZEB2|ZFAND2B|ZFP36L2|ZNF142|ZNF2|ZNF385B|ZNF513|ZNF514|ZNF638|ZNF804A|ZNF806|ZNG1B|ZRANB3|ZSWIM2		Mosaic trisomy 2	VCV001703543	2	1 - 243199373			1703543	1695934			copy number gain		Pathogenic		no assertion criteria provided							
GRCh37/hg19 2q23.3-24.1(chr2:154852961-159126250)x1	ACVR1|ACVR1C|CCDC148|CYTIP|ERMN|GALNT13|GALNT5|GPD2|KCNJ3|NR4A2|UPP2		not provided	VCV001340408	2	154852961 - 159126250			1340408	1331616			copy number loss		Pathogenic	Apr 1, 2021	no assertion criteria provided							
GRCh37/hg19 2q23.3-24.1(chr2:154328530-158759642)x1	ACVR1|ACVR1C|CYTIP|ERMN|GALNT13|GALNT5|GPD2|KCNJ3|NR4A2|RPRM		not provided	VCV001340352	2	154328530 - 158759642			1340352	1331560			copy number loss		Pathogenic	Apr 1, 2021	no assertion criteria provided							
GRCh37/hg19 2q23.3-24.2(chr2:152967964-160089210)x3	ACVR1|ACVR1C|ARL6IP6|CCDC148|CYTIP|DAPL1|ERMN|FMNL2|GALNT13|GALNT5|GPD2|KCNJ3|NR4A2|PKP4|PRPF40A|RPRM|STAM2|TANC1|UPP2		not provided	VCV001339787	2	152967964 - 160089210			1339787	1330997			copy number gain		not provided		no classification provided							
GRCh37/hg19 2q24.1(chr2:156696086-159450561)x1	ACVR1C|GALNT5|ACVR1|GPD2|UPP2|CYTIP|NR4A2|ERMN|CCDC148|PKP4		not provided	VCV000980600	2	156696086 - 159450561			980600	968678			copy number loss		Likely pathogenic	Aug 29, 2019	no assertion criteria provided							
GRCh37/hg19 2q12.1-24.3(chr2:104172062-168223828)x1	CCDC74B|CCDC93|IFIH1|IL1A|MYO7B|MZT2A|SFT2D3|TSN|TTC21B|TTL|TUBA3D|TUBA3E|TMEM37|TMEM87B|SLC20A1|SULT1C2|SULT1C3|POLR2D|POTEE|NCK2|NCKAP5|NEB|NIFK|NMI|NPHP1|SULT1C4|TANC1|STEAP3|SLC35F5|SLC38A11|STAM2|IL1B|IL36RN|IL37|IMP4|IL1F10|IL1RN|IL36A|CD302|IL36B|IL36G|MZT2B|PKP4|PLA2R1|PLEKHB2|POLR1B|CCNT2|CDRT15P3|CFC1|CKAP2L|CFC1B|CHCHD5|CYTIP|DAPL1|DARS1|ACMSD|ACOXL|ACTR3|ACVR1|ACVR1C|ACVR2A|AMER3|AMMECR1L|ANAPC1|ARHGAP15|ARHGEF4|ARL5A|ARL6IP6|BAZ2B|BCL2L11|BIN1|BUB1|C1QL2|C2orf27A|C2orf49|C2orf76|CACNB4|CCDC115|CCDC138|CCDC148|CCDC74A|CLASP1|CNTNAP5|COBLL1|CSRNP3|CXCR4|CYP27C1|DBI|DDX18|DPP10|DPP4|ECRG4|EDAR|EN1|EPB41L5|EPC2|ERCC3|ERMN|FAM168B|FAP|FBLN7|FHL2|FIGN|FMNL2|FOXD4L1|GALNT13|GALNT3|GALNT5|GCA|GCC2|GCG|GLI2|GPD2|GPR148|GPR17|GPR39|GPR45|GRB14|GTDC1|GYPC|HNMT|HS6ST1|INHBB|INSIG2|ITGB6|IWS1|KCNH7|KCNJ3|KYNU|LCT|LIMS1|LIMS2|LIMS3|LIMS4|LRP1B|LY75|LY75-CD302|LYPD1|LYPD6|LYPD6B|MALL|MAP3K19|MAP3K2|MARCHF7|MARCO|MBD5|MCM6|MERTK|MGAT5|MIR128-1|MMADHC|MRPS9|NR4A2|NT5DC4|NXPH2|ORC4|PAX8|POTEF|POTEI|POTEJ|POU3F3|PROC|PRPF40A|PSD4|PSMD14|PTPN18|PTPN4|R3HDM1|RAB3GAP1|RAB6C|RABL2A|RALB|RANBP2|RBM43|RBMS1|RGPD3|RGPD4|RGPD5|RGPD6|RGPD8|RIF1|RND3|RNU4ATAC|RPRM|SAP130|SCN1A|SCN2A|SCN3A|SCN7A|SCN9A|SCTR|SEPTIN10|SLC4A10|SLC5A7|SMPD4|SOWAHC|SPOPL|ST6GAL2|TANK|TBR1|TFCP2L1|TGFBRAP1|THSD7B|TMEM163|TMEM177|TMEM185B|TNFAIP6|UBXN4|UGGT1|UPP2|UXS1|WDR33|WDSUB1|XIRP2|ZC3H6|ZC3H8|ZEB2|ZNF806|ZNG1B|ZRANB3		Poly (ADP-Ribose) polymerase inhibitor response	VCV000523163	2	104172062 - 168223828			523163	513795			copy number loss		drug response	Nov 27, 2017	no assertion criteria provided							
GRCh37/hg19 2q24.1-24.3(chr2:157970774-169270675)x1	ACVR1|ACVR1C|B3GALT1|BAZ2B|CCDC148|CD302|COBLL1|CSRNP3|CYTIP|DAPL1|DPP4|ERMN|FAP|FIGN|GALNT3|GALNT5|GCA|GCG|GRB14|IFIH1|ITGB6|KCNH7|LY75|LY75-CD302|MARCHF7|PKP4|PLA2R1|PSMD14|RBMS1|SCN1A|SCN2A|SCN3A|SCN7A|SCN9A|SLC38A11|SLC4A10|STK39|TANC1|TANK|TBR1|TTC21B|UPP2|WDSUB1|XIRP2		See cases	VCV000443473	2	157970774 - 169270675			443473	437135			copy number loss		Pathogenic	Jun 23, 2014	no assertion criteria provided							
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384)	CCDC85A|CCDC88A|CDC42EP3|CDCA7|CDK15|CFAP210|CFAP36|CFAP65|CIMIP5|CIMIP6|CNOT9|CNPPD1|COPS8|COPS9|CRYBA2|DAPL1|DARS1|DNAJC10|DRC1|DTNB|DTYMK|DYSF|DYTN|E2F6|ECEL1|EIF2B4|EIF4E2|EPAS1|EPB41L5|FAM124B|FAM136A|FAP|FARP2|FBXO48|FER1L5|FEZ2|FHL2|FIGLA|FIGN|FKBP1B|FKBP7|FLACC1|FMNL2|FN1|FNDC4|FSIP2|FTCDNL1|FZD5|FZD7|G6PC2|FARSB|FASTKD1|FASTKD2|FAM178B|FAM98A|FBLN7|FBXO11|FBXO36|FANCL|FBXO41|EPC2|FEV|EPCAM|EML4|EML6|EMX1|EN1|EPHA4|ESPNL|ETAA1|EVA1A|FAM117B|FAM161A|FAM168B|EFHD1|EFR3B|EGR4|EHBP1|EHD3|EIF2AK2|EIF2AK3|FAM228A|FAM228B|EIF5B|ELMOD3|EMILIN1|FAM171B|DUSP11|DUSP19|DYNC1I2|DYNC2LI1|DPYSL5|DQX1|DUSP2|DUSP28|EIPR1|ECRG4|EDAR|EEF1B2|EFEMP1|DBI|DCAF17|DCDC2C|DCTN1|DDX1|DDX18|DES|DGKD|DGUOK|DHRS9|DNAJC27|DNAJC5G|DNER|DNMT3A|DOCK10|DOK1|DNPEP|CRYGA|CRYGB|CYP27C1|D2HGDH|CREB1|CREG2|CRIM1|CRIPT|CYP1B1|CYP20A1|CYP26B1|CYP27A1|CYRIA|CYS1|CYTIP|DPP10|DPP4|DPY30|CNRIP1|COL5A2|COL6A3|COL4A4|COLEC11|COMMD1|COPS7B|DAW1|COQ10B|CPO|CPS1|COX5B|COX7A2L|CIR1|CKAP2L|CNNM3|CHN1|CHPF|CHRNA1|CHRND|CHRNG|CHST10|CIAO1|CIB4|CIMIP2C|CNOT11|CPSF3|CRACDL|CMPK2|CNGA3|CDK5R2|CDKL4|CENPA|CENPO|CERKL|CERS6|GLI2|GLS|GMCL1|CDRT15P3|CD302|CEBPZ|CEP68|CNNM4|CHMP3|CCDC93|CCL20|CCDC142|CCDC148|CCDC150|CCDC74A|CCDC74B|CD8A|CD8B|CCNT2|CCNYL1|CCT4|CCT7|CD207|CD28|CFC1|CFC1B|CFLAR|CGREF1|CHAC2|CHCHD5|CLASP1|CLEC4F|CLHC1|CLIP4|CLK1|CMKLR2|CNTNAP5|COA5|COBLL1|COL3A1|COL4A3|CRYGC|CRYGD|CSRNP3|CTDSP1|CTLA4|CTNNA2|CUL3|CWC22|CXCR1|CXCR2|CXCR4|CYBRD1|DHX57|DIRC1|DIRC3|DIS3L2|DLX1|DLX2|DNAAF10|DNAH6|DNAH7|DNAJB2|DNAJB3|ERBB4|ERCC3|ERFE|ERICH2|ERLEC1|ERMN|EVX2|EXOC6B|FABP1|FAHD2A|FAHD2B|FAM110C|FOSL2|FOXD4L1|FOXI3|FOXN2|FRZB|FSHR|GAD1|GAL3ST2|GALM|GALNT13|GALNT14|GALNT3|GALNT5|GAREM2|GBX2|GCA|GCC2|GCFC2|GCG|GCKR|GDF7|GEMIN6|GEN1|GFPT1|GGCX|GIGYF2|GKN1|GKN2|GLB1L|GMPPA|GNLY|GORASP2|GPAT2|GPATCH11|GPBAR1|GPC1|GPD2|GPN1|GPR148|GPR155|GPR17|GPR35|GPR39|GPR45|GPR55|GPR75|GPR75-ASB3|GRB14|GREB1|GRHL1|GTDC1|GTF2A1L|GTF3C2|GTF3C3|GULP1|GYPC|HAAO|HADHA|HADHB|HAT1|HDAC4|HDLBP|HEATR5B|HECW2|HES6|HIBCH|HJURP|HK2|HNMT|HNRNPA3|HNRNPLL|HOXD1|HOXD10|HOXD11|HOXD12|HOXD13|HOXD3|HOXD4|HOXD8|HOXD9|HPCAL1|HS1BP3|HS6ST1|HSPD1|HSPE1|HTR2B|HTRA2|HYCC2|IAH1|ICA1L|ICOS|ID2|IDH1|IFIH1|IFT172|IFT70A|IFT70B|IGFBP2|IGFBP5|IGKC|IHH|IKZF2|IL18R1|IL18RAP|IL1A|IL1B|IL1F10|IL1R1|IL1R2|IL1RL1|IL1RL2|IL1RN|IL36A|IL36B|IL36G|IL36RN|IL37|ILKAP|IMMT|IMP4|ING5|INHA|INHBB|INO80B|INO80D|INPP1|INPP4A|INSIG2|IQCA1|IRS1|ITGA4|ITGA6|ITGAV|ITGB1BP1|ITGB6|ITM2C|ITPRID2|ITPRIPL1|ITSN2|IWS1|KANSL1L|KANSL3|KCMF1|KCNE4|KCNF1|KCNG3|KCNH7|KCNIP3|KCNJ13|KCNJ3|KCNK12|KCNK3|KCNS3|KCTD18|KDM3A|KHK|KIDINS220|KIF1A|KIF3C|KLF11|KLF7|KLHL23|KLHL29|KLHL30|KLHL41|KRCC1|KRTCAP3|KYNU|LANCL1|LAPTM4A|LBH|LBX2|LCLAT1|LCT|LDAH|LGALSL|LHCGR|LIMS1|LIMS2|LIMS3|LIMS4|LINC00570|LINC01873|LINC02898|LINC03124|LIPT1|LMAN2L|LNPK|LONRF2|LOXL3|LPIN1|LRATD1|LRP1B|LRP2|LRPPRC|LRRFIP1|LRRTM1|LRRTM4|LTBP1|LY75|LY75-CD302|LYG1|LYG2|LYPD1|LYPD6|LYPD6B|M1AP|MAB21L4|MAIP1|MAL|MALL|MAP2|MAP3K19|MAP3K2|MAP3K20|MAP4K3|MAP4K4|MAPRE3|MARCHF4|MARCHF7|MARCO|MARS2|MAT2A|MATN3|MBD5|MBOAT2|MCEE|MCFD2|MCM6|MDH1|MDH1B|MEIS1|MEMO1|MERTK|METAP1D|METTL21A|METTL5|METTL8|MFF|MFSD2B|MFSD6|MFSD9|MGAT4A|MGAT5|MIR10B|MIR1258|MIR128-1|MIR149|MIR216A|MIR217|MIR26B|MIR375|MITD1|MLPH|MMADHC|MOB1A|MOB4|MOGAT1|MOGS|MORN2|MPHOSPH10|MPP4|MPV17|MREG|MROH2A|MRPL19|MRPL30|MRPL33|MRPL35|MRPL44|MRPL53|MRPS5|MRPS9|MSGN1|MSH2|MSH2-OT1|MSH6|MSTN|MTA3|MTERF4|MTHFD2|MTIF2|MTX2|MXD1|MYCN|MYCNOS|MYL1|MYO1B|MYO3B|MYO7B|MYT1L|MZT2A|MZT2B|NAB1|NABP1|NAGK|NAT8|NAT8B|NBAS|NBEAL1|NCAPH|NCK2|NCKAP1|NCKAP5|NCL|NCOA1|NDUFA10|NDUFAF7|NDUFB3|NDUFS1|NEB|NEMP2|NEU2|NEU4|NEUROD1|NFE2L2|NFU1|NGEF|NHEJ1|NIF3L1|NIFK|NLRC4|NMI|NMS|NMUR1|NOL10|NOP58|NOSTRIN|NOTO|NPAS2|NPHP1|NPPC|NR4A2|NRBP1|NRP2|NRXN1|NT5C1B|NT5C1B-RDH14|NT5DC4|NTSR2|NUP35|NXPH2|NYAP2|OBSL1|ODC1|OLA1|OR6B2|OR6B3|ORC2|ORC4|ORMDL1|OSBPL6|OSGEPL1|OSR1|OST4|OTOF|OTOS|OTX1|OXER1|PAIP2B|PAPOLG|PARD3B|PASK|PAX3|PAX8|PCARE|PCBP1|PCGEM1|PCGF1|PCYOX1|PDCL3|PDE11A|PDE1A|PDE6D|PDIA6|PDK1|PECR|PELI1|PER2|PEX13|PFN4|PGAP1|PHOSPHO2|PID1|PIGF|PIKFYVE|PJVK|PKDCC|PKP4|PLA2R1|PLB1|PLCD4|PLCL1|PLEK|PLEKHA3|PLEKHB2|PLEKHH2|PLEKHM3|PLGLB1|PMS1|PNKD|PNO1|PNPT1|POLE4|POLR1A|POLR1B|POLR2D|POMC|POTEE|POTEF|POTEI|POTEJ|POU3F3|PPIG|PPIL3|PPM1B|PPM1G|PPP1CB|PPP1R1C|PPP1R21|PPP1R7|PPP3R1|PPP4R3B|PRADC1|PREB|PREPL|PRKAG3|PRKCE|PRKD3|PRKRA|PRLH|PROC|PROKR1|PROM2|PRPF40A|PRR21|PRR30|PRSS56|PSD4|PSMD1|PSMD14|PSME4|PTCD3|PTH2R|PTMA|PTPN18|PTPN4|PTPRN|PTRHD1|PUM2|PUS10|PXDN|QPCT|R3HDM1|RAB10|RAB11FIP5|RAB17|RAB1A|RAB3GAP1|RAB6C|RABL2A|RAD51AP2|RALB|RAMP1|RANBP2|RAPGEF4|RAPH1|RASGRP3|RBKS|RBM43|RBM44|RBM45|RBMS1|RDH14|REEP1|REG1A|REG1B|REG3A|REG3G|REL|RESP18|RETREG2|RETSAT|REV1|RFTN2|RFX8|RGPD1|RGPD2|RGPD3|RGPD4|RGPD5|RGPD6|RGPD8|RHBDD1|RHOB|RHOQ|RIF1|RMDN2|RMND5A|RNASEH1|RND3|RNF103|RNF103-CHMP3|RNF144A|RNF149|RNF181|RNF25|RNPEPL1|RNU4ATAC|ROCK2|RPE|RPIA|RPL31|RPL37A|RPRM|RPS27A|RPS7|RRM2|RSAD2|RTKN|RTN4|RUFY4|SAG|SANBR|SAP130|SATB2|SCG2|SCLY|SCN1A|SCN2A|SCN3A|SCN7A|SCN9A|SCRN3|SCTR|SDC1|SELENOI|SEMA4C|SEMA4F|SEPTIN10|SEPTIN2|SERPINE2|SERTAD2|SESTD1|SF3B1|SF3B6|SFT2D3|SFTPB|SFXN5|SGO2|SGPP2|SH2D6|SH3BP4|SH3YL1|SIX2|SIX3|SLC11A1|SLC16A14|SLC19A3|SLC1A4|SLC20A1|SLC23A3|SLC25A12|SLC30A3|SLC30A6|SLC35F5|SLC35F6|SLC38A11|SLC39A10|SLC3A1|SLC40A1|SLC4A10|SLC4A1AP|SLC4A3|SLC4A5|SLC5A6|SLC5A7|SLC66A3|SLC8A1|SLC9A2|SLC9A4|SMARCAL1|SMC6|SMPD4|SMYD1|SMYD5|SNED1|SNORC|SNORD20|SNORD82|SNRNP200|SNRNP27|SNRPG|SNTG2|SNX17|SOCS5|SOS1|SOS1-IT1|SOWAHC|SOX11|SP100|SP110|SP140|SP140L|SP3|SP5|SP9|SPAG16|SPAST|SPATA3|SPATA31H1|SPATS2L|SPC25|SPDYA|SPEG|SPHKAP|SPMIP9|SPOPL|SPP2|SPR|SPRED2|SPTBN1|SRBD1|SRD5A2|SRSF7|SSB|ST3GAL5|ST6GAL2|STAM2|STAMBP|STARD7|STAT1|STAT4|STEAP3|STK11IP|STK16|STK17B|STK25|STK36|STK39|STON1|STON1-GTF2A1L|STPG4|STRADB|STRN|SUCLG1|SULT1C2|SULT1C3|SULT1C4|SULT6B1|SUMO1|SUPT7L|TACR1|TAF1B|TANC1|TANK|TBC1D8|TBR1|TCF23|TCF7L1|TDRD15|TEKT4|TET3|TEX261|TEX44|TFCP2L1|TFPI|TGFA|TGFBRAP1|TGOLN2|THADA|THAP4|THNSL2|THSD7B|THUMPD2|TIA1|TIGD1|TLK1|TLX2|TM4SF20|TMBIM1|TMEFF2|TMEM127|TMEM131|TMEM150A|TMEM163|TMEM169|TMEM17|TMEM177|TMEM178A|TMEM18|TMEM182|TMEM185B|TMEM198|TMEM214|TMEM237|TMEM247|TMEM37|TMEM87B|TMSB10|TNFAIP6|TNP1|TNS1|TOGARAM2|TP53I3|TPO|TPRKB|TRABD2A|TRAF3IP1|TRAK2|TRAPPC12|TRIB2|TRIM43|TRIM43B|TRIM54|TRIP12|TRMT61B|TRPM8|TSGA10|TSN|TSPYL6|TTC21B|TTC27|TTC31|TTC32|TTC7A|TTL|TTLL4|TTN|TUBA3D|TUBA3E|TUBA4A|TWIST2|TXNDC9|TYW5|UBE2E3|UBE2F|UBR3|UBXN2A|UBXN4|UCN|UGGT1|UGP2|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9|UNC50|UNC80|UPP2|USP34|USP37|USP39|USP40|UXS1|VAMP5|VAMP8|VAX2|VIL1|VIT|VPS54|VRK2|VSNL1|VWA3B|VWC2L|WBP1|WDCP|WDFY1|WDPCP|WDR12|WDR33|WDR35|WDR43|WDR54|WDR75|WDSUB1|WIPF1|WNT10A|WNT6|XDH|XIRP2|XPO1|XRCC5|YIPF4|YPEL5|YWHAQ|ZAP70|ZC3H15|ZC3H6|ZC3H8|ZDBF2|ZNF512|ZEB2|ZFAND2B|ZFP36L2|ZNF142|ZNF2|ZNF385B|ZNF513|ZNF514|ZNF638|ZNF804A|ZNF806|ZNG1B|ZRANB3|ZSWIM2|AAK1|AAMP|ABCA12|ABCB11|ABCB6|ABCG5|ABCG8|ABHD1|ABI2|ACADL|ACKR3|ACMSD|ACOXL|ACP1|ACSL3|ACTG2|ACTR1B|ACTR2|ACTR3|ACVR1|ACVR1C|ACVR2A|ACYP2|ADAM17|ADAM23|ADCY3|ADD2|ADGRF3|ADI1|ADRA2B|AFF3|AFTPH|AGAP1|AGBL5|AGFG1|AGPS|AGXT|ALK|ALKAL2|ALLC|ALMS1|ALPG|ALPI|ALPP|ALS2|AMER3|AMMECR1L|ANAPC1|ANKAR|ANKMY1|ANKRD23|ANKRD36|ANKRD36B|ANKRD36C|ANKRD39|ANKRD44|ANKRD53|ANKZF1|ANO7|ANTXR1|ANXA4|AOX1|AP1S3|APLF|APOB|AQP12A|AQP12B|ARHGAP15|ARHGAP25|ARHGEF33|ARHGEF4|ARID5A|ARL4C|ARL5A|ARL6IP6|ARMC9|ARPC2|ASAP2|ASB1|ASB18|ASB3|ASIC4|ASNSD1|ASPRV1|ASTL|ASXL2|ATAD2B|ATF2|ATG16L1|ATG4B|ATG9A|ATIC|ATL2|ATOH8|ATP5MC3|ATP6V1B1|ATP6V1C2|ATP6V1E2|ATRAID|AUP1|B3GALT1|B3GNT2|B3GNT7|BABAM2|BARD1|BAZ2B|BBS5|BCL11A|BCL2L11|BCS1L|BCYRN1|BIN1|BIRC6|BMP10|BMPR2|BOK|BOLA3|BOLL|BUB1|BZW1|C1D|C1QL2|C2CD6|C2orf15|C2orf42|C2orf48|C2orf49|C2orf66|C2orf68|C2orf69|C2orf72|C2orf74|C2orf76|C2orf78|C2orf80|C2orf81|C2orf83|C2orf88|CAB39|CACNB4|CAD|CALCRL|CALM2|CAMKMT|CAPG|CAPN10|CAPN13|CAPN14|CARF|CASP10|CASP8|CATIP|CAVIN2|CCDC115|CCDC121|CCDC138|CCDC140|CCDC141		See cases	VCV000442998	2	12771 - 242783384			442998	436660			copy number gain		Pathogenic	Jul 14, 2015	no assertion criteria provided							
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384)x3	AAK1|AAMP|ABCA12|ABCB11|ABCB6|ABCG5|ABCG8|ABHD1|ABI2|ACADL|ACKR3|ACMSD|ACOXL|ACP1|ACSL3|ACTG2|ACTR1B|ACTR2|ACTR3|ACVR1|ACVR1C|ACVR2A|ACYP2|ADAM17|ADAM23|ADCY3|ADD2|ADGRF3|ADI1|ADRA2B|AFF3|AFTPH|AGAP1|AGBL5|AGFG1|AGPS|AGXT|ALK|ALKAL2|ALLC|ALMS1|ALPG|ALPI|ALPP|ALS2|AMER3|AMMECR1L|ANAPC1|ANKAR|ANKMY1|ANKRD23|ANKRD36|ANKRD36B|ANKRD36C|ANKRD39|ANKRD44|ANKRD53|ANKZF1|ANO7|ANTXR1|ANXA4|AOX1|AP1S3|APLF|APOB|AQP12A|AQP12B|ARHGAP15|ARHGAP25|ARHGEF33|ARHGEF4|ARID5A|ARL4C|ARL5A|ARL6IP6|ARMC9|ARPC2|ASAP2|ASB1|ASB18|ASB3|ASIC4|ASNSD1|ASPRV1|ASTL|ASXL2|ATAD2B|ATF2|ATG16L1|ATG4B|ATG9A|ATIC|ATL2|ATOH8|ATP5MC3|ATP6V1B1|ATP6V1C2|ATP6V1E2|ATRAID|AUP1|B3GALT1|B3GNT2|B3GNT7|BABAM2|BARD1|BAZ2B|BBS5|BCL11A|BCL2L11|BCS1L|BCYRN1|BIN1|BIRC6|BMP10|BMPR2|BOK|BOLA3|BOLL|BUB1|BZW1|C1D|C1QL2|C2CD6|C2orf15|C2orf42|C2orf48|C2orf49|C2orf66|C2orf68|C2orf69|C2orf72|C2orf74|C2orf76|C2orf78|C2orf80|C2orf81|C2orf83|C2orf88|CAB39|CACNB4|CAD|CALCRL|CALM2|CAMKMT|CAPG|CAPN10|CAPN13|CAPN14|CARF|CASP10|CASP8|CATIP|CAVIN2|CCDC115|CCDC121|CCDC138|CCDC140|CCDC141|CCDC142|CCDC148|CCDC150|CCDC74A|CCDC74B|CCDC85A|CCDC88A|CCDC93|CCL20|CCNT2|CCNYL1|CCT4|CCT7|CD207|CD28|CD302|CD8A|CD8B|CDC42EP3|CDCA7|CDK15|CDK5R2|CDKL4|CDRT15P3|CEBPZ|CENPA|CENPO|CEP68|CERKL|CERS6|CFAP210|CFAP36|CFAP65|CFC1|CFC1B|CFLAR|CGREF1|CHAC2|CHCHD5|CHMP3|CHN1|CHPF|CHRNA1|CHRND|CHRNG|CHST10|CIAO1|CIB4|CIMIP2C|CIMIP5|CIMIP6|CIR1|CKAP2L|CLASP1|CLEC4F|CLHC1|CLIP4|CLK1|CMKLR2|CMPK2|CNGA3|CNNM3|CNNM4|CNOT11|CNOT9|CNPPD1|CNRIP1|CNTNAP5|COA5|COBLL1|COL3A1|COL4A3|COL4A4|COL5A2|COL6A3|COLEC11|COMMD1|COPS7B|COPS8|COPS9|COQ10B|COX5B|COX7A2L|CPO|CPS1|CPSF3|CRACDL|CREB1|CREG2|CRIM1|CRIPT|CRYBA2|CRYGA|CRYGB|CRYGC|CRYGD|CSRNP3|CTDSP1|CTLA4|CTNNA2|CUL3|CWC22|CXCR1|CXCR2|CXCR4|CYBRD1|CYP1B1|CYP20A1|CYP26B1|CYP27A1|CYP27C1|CYRIA|CYS1|CYTIP|D2HGDH|DAPL1|DARS1|DAW1|DBI|DCAF17|DCDC2C|DCTN1|DDX1|DDX18|DES|DGKD|DGUOK|DHRS9|DHX57|DIRC1|DIRC3|DIS3L2|DLX1|DLX2|DNAAF10|DNAH6|DNAH7|DNAJB2|DNAJB3|DNAJC10|DNAJC27|DNAJC5G|DNER|DNMT3A|DNPEP|DOCK10|DOK1|DPP10|DPP4|DPY30|DPYSL5|DQX1|DRC1|DTNB|DTYMK|DUSP11|DUSP19|DUSP2|DUSP28|DYNC1I2|DYNC2LI1|DYSF|DYTN|E2F6|ECEL1|ECRG4|EDAR|EEF1B2|EFEMP1|EFHD1|EFR3B|EGR4|EHBP1|EHD3|EIF2AK2|EIF2AK3|EIF2B4|EIF4E2|EIF5B|EIPR1|ELMOD3|EMILIN1|EML4|EML6|EMX1|EN1|EPAS1|EPB41L5|EPC2|EPCAM|EPHA4|ERBB4|ERCC3|ERFE|ERICH2|ERLEC1|ERMN|ESPNL|ETAA1|EVA1A|EVX2|EXOC6B|FABP1|FAHD2A|FAHD2B|FAM110C|FAM117B|FAM124B|FAM136A|FAM161A|FAM168B|FAM171B|FAM178B|FAM228A|FAM228B|FAM98A|FANCL|FAP|FARP2|FARSB|FASTKD1|FASTKD2|FBLN7|FBXO11|FBXO36|FBXO41|FBXO48|FER1L5|FEV|FEZ2|FHL2|FIGLA|FIGN|FKBP1B|FKBP7|FLACC1|FMNL2|FN1|FNDC4|FOSL2|FOXD4L1|FOXI3|FOXN2|FRZB|FSHR|FSIP2|FTCDNL1|FZD5|FZD7|G6PC2|GAD1|GAL3ST2|GALM|GALNT13|GALNT14|GALNT3|GALNT5|GAREM2|GBX2|GCA|GCC2|GCFC2|GCG|GCKR|GDF7|GEMIN6|GEN1|GFPT1|GGCX|GIGYF2|GKN1|GKN2|GLB1L|GLI2|GLS|GMCL1|GMPPA|GNLY|GORASP2|GPAT2|GPATCH11|GPBAR1|GPC1|GPD2|GPN1|GPR148|GPR155|GPR17|GPR35|GPR39|GPR45|GPR55|GPR75|GPR75-ASB3|GRB14|GREB1|GRHL1|GTDC1|GTF2A1L|GTF3C2|GTF3C3|GULP1|GYPC|HAAO|HADHA|HADHB|HAT1|HDAC4|HDLBP|HEATR5B|HECW2|HES6|HIBCH|HJURP|HK2|HNMT|HNRNPA3|HNRNPLL|HOXD1|HOXD10|HOXD11|HOXD12|HOXD13|HOXD3|HOXD4|HOXD8|HOXD9|HPCAL1|HS1BP3|HS6ST1|HSPD1|HSPE1|HTR2B|HTRA2|HYCC2|IAH1|ICA1L|ICOS|ID2|IDH1|IFIH1|IFT172|IFT70A|IFT70B|IGFBP2|IGFBP5|IGKC|IHH|IKZF2|IL18R1|IL18RAP|IL1A|IL1B|IL1F10|IL1R1|IL1R2|IL1RL1|IL1RL2|IL1RN|IL36A|IL36B|IL36G|IL36RN|IL37|ILKAP|IMMT|IMP4|ING5|INHA|INHBB|INO80B|INO80D|INPP1|INPP4A|INSIG2|IQCA1|IRS1|ITGA4|ITGA6|ITGAV|ITGB1BP1|ITGB6|ITM2C|ITPRID2|ITPRIPL1|ITSN2|IWS1|KANSL1L|KANSL3|KCMF1|KCNE4|KCNF1|KCNG3|KCNH7|KCNIP3|KCNJ13|KCNJ3|KCNK12|KCNK3|KCNS3|KCTD18|KDM3A|KHK|KIDINS220|KIF1A|KIF3C|KLF11|KLF7|KLHL23|KLHL29|KLHL30|KLHL41|KRCC1|KRTCAP3|KYNU|LANCL1|LAPTM4A|LBH|LBX2|LCLAT1|LCT|LDAH|LGALSL|LHCGR|LIMS1|LIMS2|LIMS3|LIMS4|LINC00570|LINC01873|LINC02898|LINC03124|LIPT1|LMAN2L|LNPK|LONRF2|LOXL3|LPIN1|LRATD1|LRP1B|LRP2|LRPPRC|LRRFIP1|LRRTM1|LRRTM4|LTBP1|LY75|LY75-CD302|LYG1|LYG2|LYPD1|LYPD6|LYPD6B|M1AP|MAB21L4|MAIP1|MAL|MALL|MAP2|MAP3K19|MAP3K2|MAP3K20|MAP4K3|MAP4K4|MAPRE3|MARCHF4|MARCHF7|MARCO|MARS2|MAT2A|MATN3|MBD5|MBOAT2|MCEE|MCFD2|MCM6|MDH1|MDH1B|MEIS1|MEMO1|MERTK|METAP1D|METTL21A|METTL5|METTL8|MFF|MFSD2B|MFSD6|MFSD9|MGAT4A|MGAT5|MIR10B|MIR1258|MIR128-1|MIR149|MIR216A|MIR217|MIR26B|MIR375|MITD1|MLPH|MMADHC|MOB1A|MOB4|MOGAT1|MOGS|MORN2|MPHOSPH10|MPP4|MPV17|MREG|MROH2A|MRPL19|MRPL30|MRPL33|MRPL35|MRPL44|MRPL53|MRPS5|MRPS9|MSGN1|MSH2|MSH2-OT1|MSH6|MSTN|MTA3|MTERF4|MTHFD2|MTIF2|MTX2|MXD1|MYCN|MYCNOS|MYL1|MYO1B|MYO3B|MYO7B|MYT1L|MZT2A|MZT2B|NAB1|NABP1|NAGK|NAT8|NAT8B|NBAS|NBEAL1|NCAPH|NCK2|NCKAP1|NCKAP5|NCL|NCOA1|NDUFA10|NDUFAF7|NDUFB3|NDUFS1|NEB|NEMP2|NEU2|NEU4|NEUROD1|NFE2L2|NFU1|NGEF|NHEJ1|NIF3L1|NIFK|NLRC4|NMI|NMS|NMUR1|NOL10|NOP58|NOSTRIN|NOTO|NPAS2|NPHP1|NPPC|NR4A2|NRBP1|NRP2|NRXN1|NT5C1B|NT5C1B-RDH14|NT5DC4|NTSR2|NUP35|NXPH2|NYAP2|OBSL1|ODC1|OLA1|OR6B2|OR6B3|ORC2|ORC4|ORMDL1|OSBPL6|OSGEPL1|OSR1|OST4|OTOF|OTOS|OTX1|OXER1|PAIP2B|PAPOLG|PARD3B|PASK|PAX3|PAX8|PCARE|PCBP1|PCGEM1|PCGF1|PCYOX1|PDCL3|PDE11A|PDE1A|PDE6D|PDIA6|PDK1|PECR|PELI1|PER2|PEX13|PFN4|PGAP1|PHOSPHO2|PID1|PIGF|PIKFYVE|PJVK|PKDCC|PKP4|PLA2R1|PLB1|PLCD4|PLCL1|PLEK|PLEKHA3|PLEKHB2|PLEKHH2|PLEKHM3|PLGLB1|PMS1|PNKD|PNO1|PNPT1|POLE4|POLR1A|POLR1B|POLR2D|POMC|POTEE|POTEF|POTEI|POTEJ|POU3F3|PPIG|PPIL3|PPM1B|PPM1G|PPP1CB|PPP1R1C|PPP1R21|PPP1R7|PPP3R1|PPP4R3B|PRADC1|PREB|PREPL|PRKAG3|PRKCE|PRKD3|PRKRA|PRLH|PROC|PROKR1|PROM2|PRPF40A|PRR21|PRR30|PRSS56|PSD4|PSMD1|PSMD14|PSME4|PTCD3|PTH2R|PTMA|PTPN18|PTPN4|PTPRN|PTRHD1|PUM2|PUS10|PXDN|QPCT|R3HDM1|RAB10|RAB11FIP5|RAB17|RAB1A|RAB3GAP1|RAB6C|RABL2A|RAD51AP2|RALB|RAMP1|RANBP2|RAPGEF4|RAPH1|RASGRP3|RBKS|RBM43|RBM44|RBM45|RBMS1|RDH14|REEP1|REG1A|REG1B|REG3A|REG3G|REL|RESP18|RETREG2|RETSAT|REV1|RFTN2|RFX8|RGPD1|RGPD2|RGPD3|RGPD4|RGPD5|RGPD6|RGPD8|RHBDD1|RHOB|RHOQ|RIF1|RMDN2|RMND5A|RNASEH1|RND3|RNF103|RNF103-CHMP3|RNF144A|RNF149|RNF181|RNF25|RNPEPL1|RNU4ATAC|ROCK2|RPE|RPIA|RPL31|RPL37A|RPRM|RPS27A|RPS7|RRM2|RSAD2|RTKN|RTN4|RUFY4|SAG|SANBR|SAP130|SATB2|SCG2|SCLY|SCN1A|SCN2A|SCN3A|SCN7A|SCN9A|SCRN3|SCTR|SDC1|SELENOI|SEMA4C|SEMA4F|SEPTIN10|SEPTIN2|SERPINE2|SERTAD2|SESTD1|SF3B1|SF3B6|SFT2D3|SFTPB|SFXN5|SGO2|SGPP2|SH2D6|SH3BP4|SH3YL1|SIX2|SIX3|SLC11A1|SLC16A14|SLC19A3|SLC1A4|SLC20A1|SLC23A3|SLC25A12|SLC30A3|SLC30A6|SLC35F5|SLC35F6|SLC38A11|SLC39A10|SLC3A1|SLC40A1|SLC4A10|SLC4A1AP|SLC4A3|SLC4A5|SLC5A6|SLC5A7|SLC66A3|SLC8A1|SLC9A2|SLC9A4|SMARCAL1|SMC6|SMPD4|SMYD1|SMYD5|SNED1|SNORC|SNORD20|SNORD82|SNRNP200|SNRNP27|SNRPG|SNTG2|SNX17|SOCS5|SOS1|SOS1-IT1|SOWAHC|SOX11|SP100|SP110|SP140|SP140L|SP3|SP5|SP9|SPAG16|SPAST|SPATA3|SPATA31H1|SPATS2L|SPC25|SPDYA|SPEG|SPHKAP|SPMIP9|SPOPL|SPP2|SPR|SPRED2|SPTBN1|SRBD1|SRD5A2|SRSF7|SSB|ST3GAL5|ST6GAL2|STAM2|STAMBP|STARD7|STAT1|STAT4|STEAP3|STK11IP|STK16|STK17B|STK25|STK36|STK39|STON1|STON1-GTF2A1L|STPG4|STRADB|STRN|SUCLG1|SULT1C2|SULT1C3|SULT1C4|SULT6B1|SUMO1|SUPT7L|TACR1|TAF1B|TANC1|TANK|TBC1D8|TBR1|TCF23|TCF7L1|TDRD15|TEKT4|TET3|TEX261|TEX44|TFCP2L1|TFPI|TGFA|TGFBRAP1|TGOLN2|THADA|THAP4|THNSL2|THSD7B|THUMPD2|TIA1|TIGD1|TLK1|TLX2|TM4SF20|TMBIM1|TMEFF2|TMEM127|TMEM131|TMEM150A|TMEM163|TMEM169|TMEM17|TMEM177|TMEM178A|TMEM18|TMEM182|TMEM185B|TMEM198|TMEM214|TMEM237|TMEM247|TMEM37|TMEM87B|TMSB10|TNFAIP6|TNP1|TNS1|TOGARAM2|TP53I3|TPO|TPRKB|TRABD2A|TRAF3IP1|TRAK2|TRAPPC12|TRIB2|TRIM43|TRIM43B|TRIM54|TRIP12|TRMT61B|TRPM8|TSGA10|TSN|TSPYL6|TTC21B|TTC27|TTC31|TTC32|TTC7A|TTL|TTLL4|TTN|TUBA3D|TUBA3E|TUBA4A|TWIST2|TXNDC9|TYW5|UBE2E3|UBE2F|UBR3|UBXN2A|UBXN4|UCN|UGGT1|UGP2|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9|UNC50|UNC80|UPP2|USP34|USP37|USP39|USP40|UXS1|VAMP5|VAMP8|VAX2|VIL1|VIT|VPS54|VRK2|VSNL1|VWA3B|VWC2L|WBP1|WDCP|WDFY1|WDPCP|WDR12|WDR33|WDR35|WDR43|WDR54|WDR75|WDSUB1|WIPF1|WNT10A|WNT6|XDH|XIRP2|XPO1|XRCC5|YIPF4|YPEL5|YWHAQ|ZAP70|ZC3H15|ZC3H6|ZC3H8|ZDBF2|ZNF512|ZEB2|ZFAND2B|ZFP36L2|ZNF142|ZNF2|ZNF385B|ZNF513|ZNF514|ZNF638|ZNF804A|ZNF806|ZNG1B|ZRANB3|ZSWIM2		See cases	VCV000442997	2	12771 - 242783384			442997	436659			copy number gain		Pathogenic	Dec 2, 2014	no assertion criteria provided							
GRCh37/hg19 2q24.1-31.3(chr2:156489430-182921298)x3	ABCB11|ACVR1|ACVR1C|AGPS|ATF2|ATP5MC3|B3GALT1|BAZ2B|BBS5|CCDC141|CCDC148|CD302|CDCA7|CERKL|CERS6|CFAP210|CHN1|CHRNA1|CIR1|COBLL1|CSRNP3|CWC22|CYBRD1|CYTIP|DAPL1|DCAF17|DHRS9|DLX1|DLX2|DPP4|DYNC1I2|ERICH2|ERMN|EVX2|FAP|FASTKD1|FIGN|FKBP7|G6PC2|GAD1|GALNT3|GALNT5|GCA|GCG|GORASP2|GPD2|GPR155|GRB14|HAT1|HNRNPA3|HOXD1|HOXD10|HOXD11|HOXD12|HOXD13|HOXD3|HOXD4|HOXD8|HOXD9|IFIH1|IFT70A|IFT70B|ITGA4|ITGA6|ITGB6|ITPRID2|KCNH7|KLHL23|KLHL41|LNPK|LRP2|LY75|LY75-CD302|MAP3K20|MARCHF7|METAP1D|METTL5|METTL8|MIR10B|MIR1258|MTX2|MYO3B|NEUROD1|NFE2L2|NOSTRIN|NR4A2|OLA1|OSBPL6|PDE11A|PDK1|PHOSPHO2|PJVK|PKP4|PLA2R1|PLEKHA3|PPIG|PPP1R1C|PRKRA|PSMD14|RAPGEF4|RBM45|RBMS1|SCN1A|SCN2A|SCN3A|SCN7A|SCN9A|SCRN3|SESTD1|SLC25A12|SLC38A11|SLC4A10|SP3|SP5|SP9|SPC25|SSB|STK39|TANC1|TANK|TBR1|TLK1|TTC21B|TTN|UBE2E3|UBR3|UPP2|WDSUB1|WIPF1|XIRP2|ZNF385B		See cases	VCV000253638	2	156489430 - 182921298			253638	248086			copy number gain		Pathogenic	Jan 20, 2016	criteria provided, single submitter							
